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ABSTRACT 
  
Cancer is one of the major causes of death in the world, especially in developed 
countries. There are already many antiproliferative agents used to cure patients with 
cancer. However, many of the currently approachable medicines are synthetic 
chemicals, which are invasive and very often cause alterations in healthy cells. Because 
of these reasons, there is a tendency to turn back to natural agents used mainly 
traditionally in folk medicine, because some of them might be potentially effective 
against tumor development.  
 In this study, the cytotoxic effects of basil, laurel and juniper extracts 
on neuroblastoma cancer cells were tested by using MTT and LDH assays. The extracts 
at concentrations 2; 0,5; 0,1; 0,05 and 0,01 mg/ml were effecting the cells for 12 hours. 
Another method used for studying of extract’s effects was western blotting analysis 
showing the level of tumor supressor p53 protein in the neuroblastoma cells after extract 
treatment. The results with treated cells were compared to the untreated cells serving as 
a control. 
 The results of MTT assay show decrease in cell viability of cells treated with all 
three plant extracts at concentration 2 mg/ml. Also four other concentrations of laurel 
and juniper extracts 0,5; 0,1; 0,05 and 0,05 mg/ml highly decreased the cell viability in 
comparison to control. Basil extract was effective only at concentration 2 mg/ml. The 
results of LDH assay show significant decrease in cell viability by cells treated with all 
three extracts at concentration 2 mg/ml. The other concentrations of all three extracts 
did not significantly decrease the cell viability compared to control. The reason for 
different results in MTT and LDH assay probably consists in different mechanisms of 
methods MTT and LDH assay. It is also possible that the mitochondria of cells does not 
work any more whilst the cell integrity is not disturbed yet. Western blotting analysis 
with 0,1 mg/ml concentration of laurel extract did not show any significant differences 
in p53 protein level compared to control even after longer incubation time (72 hours) 
with the extract. Cells treated with the basil extract at concentration 0,5 mg/ml showed 
little higher p53 level after 24 and 30 hours of incubation compared to control.  
As the results of this study imply, laurel, basil and juniper extracts have 
cytotoxic effects on SH-SY5Y human neuroblastoma cells and might also influence the 
p53 level. These activitities depend on the concentration of extract and incubation time.   
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ABSTRAKT 
 
Rakovina je jednou z hlavních příčin smrti ve světě, především ve vyspělých 
zemích. Existuje jiţ celá řáda antiproliferativních látek, pouţívaných k léčení pacientů. 
Ovšem mnoho při léčbě rakoviny dnes pouţívaných látek jsou syntetické produkty, 
které jsou často invazivní a způsobují poškození rovněţ zdravých buněk. To jsou 
důvody tendence vracet se zpět k přírodním látkám, které byly odedávna pouţívany 
v lidové medicíně a některé z nich jsou potenciálně účinné proti rozvoji nádorů. 
Ve své práci jsem studovala cytotoxické účinky extraktů z jalovce, vavřínu 
a bazalky na buňky neuroblastomu pomocí MTT a LDH testů. Extrakty v koncentracích 
2; 0,5; 0,1; 0,05 a 0,01 mg/ml působily na buňky po dobu 12 hodin. Ke studiu účinků 
extraktů byla pouţita také western blotting analýza, pomocí níţ byla zjišťována hladina 
tumor supresorového p53 proteinu v buňkách po působení extraktů. Ve všech testech 
byly výsledky experimentů s buňkami, na něţ extrakt působil, srovnáván s výsledky 
experimentů s buňkami, na něţ extrakt nepůsobil a které tedy slouţily jako kontrola. 
Výsledky MTT testů ukazují pokles ţivotaschopnosti buněk v experimentech, 
ve kterých byly pouţity všechny tři extrakty v koncentraci 2 mg/ml. Velmi účinná se 
ukázala být koncentrace 0,5 mg/ml extraktu z vavřínu. Také ostatní koncentrace vavřínu 
a jalovce značně sniţovaly ţivotaschopnost buněk ve srovnání s kontrolou. Bazalka 
v jiné koncentraci neţ 2 mg/ml ţivotaschopnost buněk výrazně nesniţovala. Výsledky 
LDH testů ukazují výrazný pokles ţivotaschopnosti buněk působením všech tří extraktů 
v koncentraci 2 mg/ml. Ostatní koncentrace všech tří extraktů nevykazují výrazné 
účinky. Rozdíly ve výsledcích MTT a LDH testů mohou být způsobeny tím, ţe 
mitochondrie jiţ nefungují, ale zatím nedošlo k poruše integrity buňky, jinými slovy 
rozdílným mechanismem metod MTT a LDH assay. Výsledky western blotting analýzy 
s extraktem z vavřínu o koncentraci 0,1 mg/ml nevykazoval signifikantní rozdíly 
v hladině proteinu p53 oproti kontrolnímu vzorku, ani po delší inkubaci s extraktem po 
dobu 72 hodin. V případě extraktu z bazalky o koncentraci 0,5 mg/ml byly hladiny 
proteinu p53 oproti kontrole mírně zvýšeny po 24 a 30 hodinách inkubace s extraktem.  
Výsledky této práce ukazují, ţe extrakty z jalovce, vavřínu a bazalky mají 
cytotoxický efekt na lidské SH-SY5Y buňky neuroblastomu a pravděpodobně mají vliv 
také na hladinu proteinu p53 v těchto buňkách. Tyto vlastnosti závisí především 
na koncentraci extaktů a na době, po kterou na buňky neuroblastomu působí. 
 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ACKNOWLEDGEMENT:  
 
 I would like to thank Doc. Atso Raasmaja and Prof. Raimo Hiltunen for their 
kind and friendly supervision and help. 
I would also like to express special thanks to M.Sc. Tiina Lantto, postgraduate 
student, for her excellent leadership, valuable consulting, and efforts to maintaining 
a friendly atmosphere in the laboratory and great help. 
 7 
ABBREVIATIONS 
 
AIF   apoptosis inducing factor 
APS   ammonium persulfate 
APAF-1  apoptosis protease activating factor 1 
ATP   adenosintriphosphate  
β-ACTIN  one of the non-muscle cytoskeletal actins 
BCA   bicinchoninic acid 
BCL-2, BCL-XL anti-apoptotic proteins 
BH   Bcl-2 homology 
BID   pro-apoptotic protein 
BAX, BAK  pro-apoptotic proteins 
BSA   bovine serum albumin  
CAPE   caffeic acid phenetyl ester  
CCD   charge-coupled device 
CD95   death receptor 
DR5   death receptor 
CO2   carbonium oxide 
DD   death domains 
DED   death effector domain 
DISC   death-inducing signalling complex 
DMEM  Dulbecco’s modified eagle’s medium 
DMSO  dimethyl sulfoxide 
DNA   deoxyribonucleic acid 
EDTA   ethylenediaminetetraacetic acid 
EMSA   electrophoretic mobility shift assay 
FADD   Fas-associating protein with death domain 
FAS/APO-1  death receptor gene  
FAS L   Fas ligand 
FBS   foetal bovine serum  
H2O2   hydrogen peroxide  
HEPES  4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid 
HBSS   Hank’s buffered salt solution 
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HCl   hydrochloric acid 
IAP   apoptosis inhibitory protein 
INT   iodonitrotetrazolium salt 
IgG   immunoglobulin G    
KCl   potassium chloride 
KH2PO4  potassium dihydrogen phosphate 
LDH   lactate dehydrogenase     
MAPK  mitogen-activated protein kinase 
MDM2  murine double minute oncogene 2 
MDMX  murine double minute oncogene 4 
MgCl2   magnesium chloride 
MOM(P)  mitochondrial outer membrane (pore)            
MTT   {3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromid} 
NaCl   sodium chloride 
NADH  nicotinamide adenine dinucleotide  
NADPH  nicotinamide adenine dinucleotide phosphate 
NaHCO3  sodium hydrogen carbonat 
Na2HPO4   sodium hydrogen phosphate 
NEAA   non-essential aminoacids 
NF- κB  nuclear factor kappa B 
NOXA  protein modulator of p53-induced apoptosis 
p53   tumor supressor protein 
PAL   phenylalanine ammonialyase 
PBS   phosphate buffered saline 
PKC   protein kinase C 
PUMA  protein modulator of p53-induced apoptosis 
RT   room temperature 
ROS   reactive oxygen species 
SDS   sodiumlauryl sulphate 
SDS-PAGE  sodiumlauryl sulphate polyacrylamide gel electrophoresis 
SEM   standard error of a mean 
SH-SY5Y  human neuroblastoma cells 
SMAC/DIABLO second mitochondrial activator of caspases/ direct IAP-binding    
   protein of low isoelectric point 
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tBID   truncated Bid 
TBS   tris-buffered saline 
TP53   tumor supressor gene 
TEMED  N, N, N‘, N‘-tetramethylethylenediamine 
TNF   tumor necrosis factor 
TNF-α   tumor necrosis factor α 
TNFR-1  tumor necrosis factor receptor 1 
TRAIL  TNF-related apoptosis inducing ligand 
TTBS   TBS with Tween   
UV radiation  ultraviolet radiation     
VEGF   vascular endothelial growth factor                  
XIAP   X-linked IAP 
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1. INTRODUCTION 
1.1. Cell death  
1.1.1. Apoptosis and necrosis 
 
 Cell death plays an important role in the multicellular organisms. There are two 
distinct main ways of cell death – apoptosis and necrosis which vary morphologically 
and physiologically. 
Apoptosis, in otherwords programmed cell death, is a physiologic, on genetical 
level highly regulated and energy-dependent cell suicide mechanism (controlled cell 
deletion), which appears to play a complementary but opposite role to mitosis. The cells 
participate in their own destruction (Kerr et al. 1972, Kinloch et al. 1999). Apoptosis is 
essential in multicellular (adult) organisms for removing of unwanted, damaged, 
extraneous, superfluous and old cells and is very important to maintain homeostasis 
under physiological conditions and in response to different internal and external stimuli. 
Apoptosis is important in tissue embryonic development during organogenesis and 
normal function maintence of the immune system (Mosmann 1983) and behaviour 
control during pathological states. Cells die during tissue regeneration in the adult 
organism (Ashkenazi and Dixit 1998). Apoptosis can be initiated by environmental 
stimuli, physiological and also pathological (Iacobini et al. 2001), such as cellular stress 
(genotoxic damage, oxidative stress or anti-neoplastic drugs) (Stennicke et al. 1998). 
 The main characteristics of apoptosis are cell shrinkage with cell integrity being 
not disturbed, plasma membrane blebbing, chromatin condensation, nuclear 
fragmentation and creation of nuclear bodies (Daugas et al. 2000, Adrain et al. 2001). 
The structure of organelles is preserved. The membrane integrity maintenances until 
very late stages in the death process (Kinloch et al. 1999). The mitochondrial membrane 
depolarization occurs in the initiation phase of apoptosis (Yang et al. 1997). There is no 
increased membrane permeability, depletion of ATP or changes in ion content at a time 
when chromatin and cytoplasm condensation occurs (Wyllie et al. 1980). The cells are 
separated from each other and form membrane bounds called apoptotic bodies. 
The apoptotic bodies contain closely packed fractions of cytoplasm and nucleus and are 
chemically and structurally intact (Kerr et al. 1972). The apoptotic bodies give signal 
by exposing phosphatidylserine on the outer surface of plasma membrane. Thus, they 
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are recognized, phagocyted and digested by phagocytes (Kerr et al. 1972, Iacobini et al. 
2001) or taken up by the adjacent epithelial ingesting cells. Phagosomes containing 
apoptotic bodies fuse with the lysosomes of the ingesting cells and are digested 
by lysosomal enzymes. The nondigestable rests of cells stay in the secondary 
lysosomes, which disappear soon in cell defecation. Inflammation does not develop 
(Wyllie et al. 1980). The process of apoptosis is typified in Figure 1. (Kerr et al. 1972). 
 Poorly functioned cell death leads to diseases or disorders. Insufficient apoptosis 
can manifest as cancer or autoimmunity, while accelerated apoptosis is evident in acute 
and chronic degenerative diseases, such as Alzheimer’s disease, developmental 
disorders, immunodeficiency and infertility (Richardson and Kumar  2002).  
 
 
Figure 1. The process of apoptosis (Kerr et al. 1972). 
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 Necrosis is a pathological type of cell death mostly caused by serious noxious 
(physical or chemical) stimuli (Kerr et al. 1972), such as toxins, ischemia, 
hyperthermia, hypoxia or metabolic poisons. It is probably the result of an irreversible 
disturbance of homeostatic mechanisms. This process does not control cell population 
and is not influenced by intrinsic factors as it is by apoptosis. Changes of tissues and 
organs, such as swelling of cytoplasm, rupture of nuclear and organelles, creation 
of flocculent matrix densities in mitochondria, desintegration of ribosomes, enhanced 
permeability of plasmalema and cellular membrane (causing changes in the cellular 
volume), are characteristic for necrosis. More calcium ions come into the cell with the 
increased permeability of cellular membrane. High concentrations of calcium ions 
within mitochondria damage respiratory apparatus. The cells lose energy in form 
of ATP. All these processes are not compatible with life of the cell. The result 
of necrosis is exudative inflammation, because groups of cells are damaged and several 
components release from the cytosol (Wyllie et al. 1980, Lossi and Merighi 2003). 
The main morphological, physiological and biochemical differences between apoptosis 
and necrosis are described in Table 1. for better orientation and clearness in the 
conception of apoptosis and necrosis (Pospěchová 2004). 
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NECROSIS APOPTOSIS 
Morfological features: 
 
- loss of membrane integrity  
 
- begins with swelling of cytoplasm and 
mitochondria 
 
- ends with total cell lysis 
 
- no vesicle formation, total lysis 
 
- desintegration of organelles 
 
- membrane blebbing, but no loss of 
integrity 
 
- begins with shrinking of cytoplasm and 
condensation of nucleus 
 
- ends with fragmentation of cell into 
apoptotic bodies 
 
- mitochondria becomes leaky due to pore 
formation involving proteins of the bcl-2 
family 
Physiological features: 
 
- affects group of contiguous cells 
 
- induced by non-physiological 
disturbancies (lytic viruses, ischemia, 
hypoxia, hypotermia, metabolic poisons) 
 
- phagocytosis by macrophages 
 
- significant inflammatory response 
 
- affects individual cells 
 
- induced by physiological stimuli (lack of 
growth factors, changes in hormonal 
environment) 
 
- phagocytosis by adjacent cells or 
macrophages 
 
- no inflammatory response 
Biochemical features: 
 
- loss of regulation of ion homeostasis 
 
- no energy requirement (passive process,      
also occurs at 4 ºC)  
 
- random digestion of DNA  
 
- postlytic DNA fragmentation (= late 
event of death) 
 
- tighly regulated process involving 
activation and enzymatic steps 
 
- energy (ATP)-dependent (active process, 
does not occur at 4 ºC) 
 
- non-random mono- and oligonucleosomal 
length fragmentation of DNA  
 
- prelytic DNA fragmentation 
 
- release of various factors (cytochrome c, 
AIF) into cytoplasm by mitochondria 
 
- activation of caspase cascade 
 
- alterations in membrane asymmetry (i.e., 
translocation of phosphatidylserine from 
the cytoplasmatic to the extracellular side 
of the membrane) 
Table 1. Morphological, physiological and biochemical differences between apoptosis 
and necrosis (Pospěchová 2004). 
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1.1.2. Molecular mechanism of apoptosis 
 
 The process of cell death is regulated by many different apoptosis–associated 
genes and proteins, which are located in cell membrane, cytosol, endoplasmic 
reticulum, mitochondrion and nucleus. The proteins can be divided into four groups: 
receptors, adaptors, regulators and executioners (Pospěchová 2004). 
 The executioners are presented by capases (cystein-aspartyl proteases). Caspases 
are constantly expressed in normal cells as inactive zymogens or pro-enzymes, called 
pro-caspases (Fadeel and Orrenius 2005). The pro-caspases undergo proteolytic process 
after receiving of death signal and create an active enzyme. Activated caspases cleave 
and activate other caspases and proteins during apoptosis. These processes are then 
responsible for many of the morphological changes, which the cells undergo during 
apoptosis (Slee  et al. 1999). 
 There are two main types of caspases: initiators (upstream) and effectors 
(downstream) (Fadeel and Orrenius 2005). Initiators (also called signalling caspases), 
such as caspase -2, -8 and -10, are autocatalyticly activated and function as activators 
of the effector caspases (Fadeel and Orrenius 2005). Effectors (also called 
executioners), such as caspase -3, -6 and -7 are able to directly degradate multiple 
substrates including the structural and regulatory proteins in the cell nucleus, cytoplasm 
and cytoskeleton. They initiate apoptosis and their activation lead to typical apoptotical 
morphological features (Danial and Korsmeyer 2004, Thornberry and Lazebnik 1998). 
They respond to many apoptotic stimuli, such as ligation of death receptors of TNFR-1 
receptor family, which results in cleavage and activation of other factors and 
manifesting of apoptosis. The executioners are not directly activated by receptor 
ligation, they are at first activated by upstream initiator caspases (Stennicke et al. 1998). 
Activation of caspase-3 is very important in the transmission of proteolytic signal 
(Stennicke et al. 1998). 
 Besides initiators and effectors, there are caspases, such as caspase -1, -4 and -5, 
that are involved in the cytokine maturation and thus in the process of inflammation. 
Caspase-12 is phylogenetically related to the cytokine maturation caspases. But in mice 
it has been proposed as a mediator of apoptosis induced by endoplasmic reticulum stress 
suggesting that it might contribute to the pathogenesis of Alzheimer's disease (Saleh 
2004). Caspases contain two important domains - CARD, caspase recruitment domain, 
and DED, death effector domain. These domains are necessary for binding of caspases 
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to their adaptors, which allow their activation. For example, the CARD of caspase-9 is 
required  for  its  recruitment  by  binding  to  Apaf-1 in  DISC. CARD   binds  to  the 
N-terminus of Apaf-1 (Richardson and Kumar 2002). 
 However, not only caspases, but also other proteases participate on caspase 
activation and apoptosis. For example, granzyme B is a serine protease that can activate 
several members of the caspase family, such as caspase -3 and -9 (Greenberg et al. 
1996, Deiss et al. 1996). Perforin is required for the entrance of this enzyme into the 
cell. It forms pores in cell membrane allowing granzyme B to enter the cell and initiate 
apoptosis (Deiss et al. 1996). 
  
1.1.3. Intrinsic (mitochondrial) pathway 
 
In mammals, there are two main pathways of apoptosis, which are mediated 
by caspases – intrinsic and extrinsic (Fadeel and Orrenius 2005). Mitochondria plays 
an important role in the intrinsic apoptotic pathway. Several pro-apoptotic proteins are 
released from mitochondrial intermembrane space into the cytosol in response 
to apoptotic stimuli (chemical-, radiation- or oxidation-induced damage). These proteins 
promote apoptosis either by activating of caspases or by neutralizing of cytosolic 
inhibitors of this process (Danial and Korsmeyer 2004, Twiddy and Cain 2007). 
 For example, cytochrome c is released under apoptotic stimuli from the 
mitochondrial inner membrane into the cytosol, which occurs before mitochondria 
begins to swell (Danial and Korsmeyer 2004). Cytochrome c is released from the 
mitochondria either by rupture of the outer mitochondrial membrane or by so-called 
mitochondrial permeability transition. This transition is controlled by a voltage- and 
Ca
2+
-sensitive pore (Blatt and Glick 2001). Released cytochrome c oligomerizes and 
creates a complex called apoptosome by binding to the cytosolic adaptor protein Apaf-1 
(apoptotic protease-activating factor-1) (Yu et al.  2005,  Twiddy and Cain 2007).  
 Apoptosome causes oligomerization and thus recruitment of procaspase-9. 
Autocatalyticly activated caspase-9 activates caspases, that lie downstream of caspase-9 
(Nakabayashi et al. 2006, Twiddy and Cain 2007). Cytochrome c/ apoptosome-
mediated caspase activation appears to result in swelling of the mitochondrial matrix 
and rupture of the inner and outer mitochondrial membrane (Adrain et al. 2001). After 
cytochrome c is released from mitochondria into cytosol, mitochondrial membrane 
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depolarization occurs together with morphological events, such as chromatin 
condensation and DNA fragmentation (Yang et al. 1997). 
 
1.1.4. Extrinsic (death receptor) pathway 
  
 The extrinsic apoptotic pathway, also called death receptor-mediated pathway, 
involves death receptors. Death receptors are cell surface receptors, which are 
composed from proteins possessing protein motifs - cytoplasmic death domains (DD) 
and cystein rich extracellular death effector domains (DED) (Danial and Korsmeyer 
2004). To the death receptors belong CD95 (also calles Apo-1 or Fas), tumor necrosis 
factor receptor, such as TNFR-1 (Hengartner 2000) and DR5, which all come from the 
tumor necrosis factor receptor superfamily (Walczak and Hass 2008, Thornberry and 
Lazebnik 1998). 
 Extrinsic apoptotic pathway is initiated by the oligomerization of death receptors 
by their ligands (FasL, TNF-alpha and TRAIL), that are members of the tumor necrosis 
factor (TNF) superfamily. Together they create a death-inducing signalling complex 
(DISC). Part of this complex is the adaptor protein FADD (Fas-associating protein with 
death domain). DISC activates procaspase-8 via binding to the DED of FADD 
(Walczak and Hass 2008, Blatt and Glick 2001). Procaspase-8 is autocatalyticly 
activated and subsequently functions as an activator of downstream effector caspases, 
such as caspase -3 and -7. Caspase-3 then mediates cleavage of proapoptotic Bid, which 
results in its translocation into the mitochondria and release of cytochrome c and Smac. 
The apoptosis is triggered through this process (Fadeel and Orrenius 2005). Caspase-8 
activates also other downstream effector caspases such as caspase-9. This process also 
leades to apoptosis (Danial and Kosrmeyer 2004, Thornberry and Lazebnik 1998), 
because caspase-9 cleaves and activates other caspases, such as caspase -2, -3, -6, -7, -8 
and -10, and thereby propagates the death signal (Slee et al. 1999). 
 Death receptors can activate death caspase within seconds after the ligand binds. 
Apoptotis demise of cells takes then a few hours (Thornberry and Lazebnik 1998). 
The apoptosis-inducing capacity of TNF receptors depends on the presence of death 
domains (DD) in the intracellular portion of receptor protein. The death domains are 
necessary for binding of death receptors to their ligands (Walczak and Hass 2008). 
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The integration between the death-receptor and mitochondrial pathway is 
provided by caspase-3 activation. The ,,cross-talk‘‘ is minimal under most conditions 
and these two apoptotic pathways work mostly undependently (Hengartner et al. 2000). 
In order to summarize the mechanisms of apoptosis, Figure 2. shows the scheme 
of apototic pathways (Maňáková 2003).  
 
Figure 2. Scheme of the apoptotic pathways (Maňáková 2003). 
 
1.1.5. p53 
 
 p53 is a protein, which functions biochemically as a transcription factor, that 
binds to a specific DNA sequence in order to activate transcription of target genes. p53 
functions also biologically as a tumor supressor and as a stress sensor (Gomez-Lazaro et 
al. 2004, Benchimol et al. 2001).  
p53 is activated upon stress and proliferative signals, such as genotoxic (gamma 
irradiation, UV radiation, cytotoxic drugs, chemical carcinogens) or non-genotoxic 
(hypoxia, hyperthermia), virus infection or DNA damage. Its activation leads 
to protection of cells and inhibition of tumor-cell growth. p53 lives shortly in most 
of the cell types, 5 to 20 minutes. The levels of the protein are influenced by several 
mechanisms. Increasing of the level and prolonging its half-life and therefore 
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stabilization, eventually activation of the protein can happen in stressful situations 
described (Gomez-Lazaro et al. 2004, Vousden and Lu 2002).   
 Two important proteins MDM2 and MDMX participate in the regulation of p53. 
MDM2 participates in the autoregulatory loop of p53. It is an ubiquitin ligase which 
targets p53 to degradation. Therefore, the activation and stabilization of p53 is 
principally associated with the inhibition of MDM2 function (Vousden and Lu 2002). 
 
1.1.5.1. Functions of p53  
 
 The main function of p53 is to inhibit the cell growth, namely it makes the cells 
to undergo one of two processes: arrest in the G1 phase of the cell cycle or genetically 
programmed cell death (higher levels of p53) (Gomez-Lazaro et al. 2004). Low levels 
of p53 lead to the cell arrest in the G1 phase, which means that p53 stops the cell in the 
G1. Before the cell cycle continues, the cell has time to repair its DNA in order 
to conserve the genome. If the cell is not able to restore its DNA, p53 induces activation 
of apoptotic signalling pathway in the cell (Gomez-Lazaro et al. 2004). 
 The localization of p53 is very important for its function (Fridman and Lowe 
2003). p53 in the latent form is situated in the cytoplasm, while p53 in the activated 
form translocates into other organelles (Gomez-Lazaro et al. 2004). p53-mediated 
apoptotic pathway can be devided into two groups: transcription-dependent, proceeding 
in the nucleus, and transcription independent, proceeding in the cytosol and 
mitochondria. These two ways work in concert to ensure that apoptotis proceeds 
efficiently (Fridman and Lowe 2003). 
 Transcription-dependent pathway in the nucleus involves p53-mediated 
induction of apoptosis by transcriptional regulation of its downstream target genes. This 
process leads to the activation of proapoptotic genes, transcriptional repression of anti-
apoptotic genes and cellular survival genes, such as survivin in both mitochondrial and 
death receptor pathways. For example, p53-induced growth arrest is achieved mainly 
by transactivation of the direct target gene p21, which induces cell arrest in G1 phase 
and prevents the entry to S-phase (Sun 2006, Gomez-Lazaro et al. 2004). The nucleus 
localization is necessary also for supressor function of p53 (Gomez-Lazaro et al. 2004).  
 Transcription-independent p53-induced pathway plays an important role in the 
cytoplasmic pathway. Cytoplasmic p53 directly activates the proapoptotic protein Bax 
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and promotes the mitochondrial outer-membrane permeabilization (MOMP). When 
MOMP occurs, proapoptogenic factors cytochrome c and Smac are released from the 
mitochondria, caspases are activated and apoptosis is triggered (Chipuk et al. 2005). 
Transcription-independent pathway is involved also in the mitochondrial apoptotic 
pathway and occurs mainly in the presence of high intracellular levels of p53 (Moll et 
al. 2005). Upon apoptotic stimuli, p53 translocates into the mitochondria, where it 
participates in the induction of apoptosis by modulating activity of mitochondrial 
proteins (Sun 2006). For example, p53 interacts with the antiapoptotic Bcl-2 family 
members Bcl-2 and Bcl-xL and antagonizes their antiapoptotic stabilization of the outer 
mitochondrial membrane. Bcl-2 and Bcl-xL can also sequester the pro-apoptotic 
members of Bcl-2 family, such as Bax and Bak. p53 is able to liberate them from the 
complex with Bcl-2 and Bcl-xL and activate their oligomerization. p53 also supports 
mitochondrial membrane permeabilization and cytochrome c release (Moll et al. 2005). 
 p53 induces also other pro-apoptotic members of the Bcl-2 family of proteins, 
such as Puma and Noxa. Puma mediates p53-induced cell death through the cytochrome 
c/ Apaf-1-dependent pathway and caspase -3 and -9 pathway. Noxa translocates upon 
apoptotic signal from cytosol into mitochondria and interacts with the permeability pore 
and thus induces apoptosis (Gomez-Lazaro et al. 2004, Benchimol et al. 2001). 
All these fuctions mean, that p53 is working not only through the activation of target 
genes, but also through its interaction with other proteins (Gomez-Lazaro et al. 2004). 
p53 functions are regulated and controlled through several mechanisms, for example 
by p53 transcription and translation, protein stability, post-translational modifications, 
and subcellular localization (Gomez-Lazaro et al. 2004).  
 
1.1.5.2. p53 and human diseases 
 
 About a hundred thousand cells are produced every second by mitosis and 
a similar number die by apoptosis in every human being. Therefore, the balance 
between cell death and proliferation are very important. A dysbalance or dysregulation 
of homeostasis and apoptosis (too little or too much of apoptosis, or apoptosis in the 
wrong time or at the wrong place) can cause several human diseases, either 
degenerative or proliferative (Fadeel and Orrenius 2005). For example, high levels 
of p53 were found in autoimmune diseases, ischemia/ reperfusion and heart failure, 
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cancer or neurodegenerative disorders (atherosclerotic lesions, multiple sclerosis, 
arthritis, Alzheimer’s disease or Huntigton’s disease). On the other hand, dysfunction 
of apoptosis leads to the cellular immortalization, genomic instability, inappropriate 
survival, allowing the continued proliferation and evolution of damaged cells (Fridman 
and Lowe 2003).  It was also reported, that the inhibition of p53 in Parkinson’s disease 
reduces the degeneration of dopaminergic neurons (Gomez-Lazaro et al. 2004, Fadeel 
and Orrenius 2005). 
 
1.1.5.3. p53 and cancer 
 
 Mutations of p53 are very often observed in human cancer (Vousden and Lu 
2002). Tumor cells, in which p53 is inactivated by mutations, are genetically unstable. 
These cells therefore accumulate mutations and chromosomal rearrangements, which 
lead to the progressive conversion of normal cells into cancer cells and to uncontrolled 
growth (Li et al. 1998, Fadeel and Orrenius 2005). 
 The mutations are caused by different mechanisms, such as mutation within the 
TP53 gene (encodes p53), mutation of downstream mediators of p53 function 
or disruption of cell-growth-inhibitor pathway (for example loss of components 
of caspase-cascade, such as caspase-9 or Apaf-1). Mutation of TP53 gene appears 
in about half of all cancers and leads to the expression of mutant p53 protein. Mutant 
p53 has a transformed activity, namely it contributes to tumor development (Vousden 
and Lu 2002), because of encoding of defective products (Benchimol et al. 2001). 
Mutations of p53 and apoptosis resistance lead to decreased apoptosis and typically 
to the failure in cancer therapy (Sun 2006)  
 Cancer cells, in comparisson to normal cells, are very sensitive to apoptotic 
stimuli and usually survive only because of the alterations in their p53 protein. Cell 
death is thus prevented by them. The alterations cause inactivation of the p53 tumor-
supressor pathway and enable them to evade the death signals. Principally, loss of p53 
is necessary for tumour cells to continue in growth and survival (Vousden and Lu 
2002). 
 The mutation or alterations can affect not only p53, but any part or target of p53-
dependent apoptotic pathway. For example, the disruption of Apaf-1 and caspase-9, 
which serve as downstream effectors of p53-dependent apoptosis, facilitates oncogenic 
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transformation and tumor development. Deregulation of members of the Bcl-2 family 
of apoptosis protein is also common in cancer (Fadeel and Orrenius 2005).  
 The goal of nowadays studies is to find ,,drugable‘‘ targets in p53 signalling 
pathway, that modulate p53-induced apoptosis. It can be for example apoptosis inducing 
genes (Sun 2006). Another goal is to find a therapy, which would reactivate p53 
(Vousden and Lu 2002). Indeed, even these forms of cancer treatment would not have 
to be without problems. It was shown, that acute p53 activation can contribute to the 
side effects of cancer therapy and chronic p53 activation can contribute to aging 
(Fridman and Lowe 2003).  
  
1.1.6. Bcl-2 protein family 
 
 The Bcl-2 family of proteins contains proapoptotic as well as antiapoptotic 
members in mammals. They can be derived into three main subclasses, which are 
defined through different degree of homology within four conserved parts called Bcl-2 
homology BH1-4 domains. This domain homology influences the structure and 
functions of proteins and are necessary for binding of proteins with each other and 
thereby influencing each other in the functions (Danial and Korsmeyer 2004). 
 
1.1.6.1. Bcl-2, Bcl-xL 
 
 The antiapoptotic members, Bcl-2 and Bcl-xL have conservation in all four 
BH1-4  domains (Danial and Korsmeyer 2004). They function as apoptosis inhibitors 
and regulate the activation of caspases (Hu et al. 1998). Bcl-2 and Bcl-xL are integral 
proteins, situated on the outer mitochondrial membrane. They present a critical 
intracellular checkpoint in the intrinsic apoptotic pathway (Danial and Korsmeyer 
2004). Overexpression of these proteins prevents apoptosis by cells, because both Bcl-2 
and Bcl-xL block the interaction between Apaf-1 from DISC and caspase-9. Thus, they 
obstruct release of cytochrome c from mitochondria into cytosol in the initiation phase 
of apoptosis. And they block also caspase-activation and DNA fragmentation, which 
would come after the release of cytochrome c (Yang et al. 1997, Hu et al. 1998). 
 Bcl-2 prevents mitochondrial membrane depolarization, which appears in the 
initiation phase of apoptosis. In otherwords, Bcl-2 principally protects cells from losing 
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of their mitochondrial membrane potential and thus release of cytochrome c (Yang et al. 
1997). Bcl-2 and Bcl-xL bind to BH3-only molecules, so that proapoptotic Bax and Bak 
can not be activated (Danial and Korsmeyer 2004). (more about BH-3 only molecules, 
Bax and Bak in the chapters 1.1.6.2. and 1.1.6.3). Bcl-2 prevents apoptosis, which is 
triggered by genotoxic damage, glucocorticoids, chemotherapeutic drugs, but it does not 
prevent apoptosis induced by death receptors (Stennicke et al. 1998).  
 
1.1.6.2. Bax and Bak 
 
 The propapoptotic members, Bax and Bak possess BH1, BH2 and BH3 domain. 
They play an important role in the intrinsic apoptotic pathway. Bax and Bak exist 
in their inactive form of monomers in the viable cells. Inactive Bax can be found 
in cytosol and inactive Bak resides in the mitochondria. When the death signal comes 
or under apoptotic stimuli, both Bax and Bak interpose into mitochondrial outer 
membrane (MOM). This process is accompanied with the releasing of intermembrane 
space proteins, such as cytochrome c (Danial and Korsmeyer 2004). 
 Bax and Bak activity can be blocked by binding to the anti-apoptotic members 
of Bcl-2 family of proteins, such as Bcl-2 or Bcl-xL. Bax and Bak are active 
in homodimeric form, but inactive in the heterodimeric form with the anti-apoptotic 
members, so they are regulated indirectly by downregulation of its anti-apoptotic 
antagonists (Cregan et al. 1999). 
 
1.1.6.3. BH3-only proteins 
 
 This group of pro-apoptotic members of Bcl-2 family has homology only within 
one death domain, the BH-3. Therefore, they are called BH3-only proteins (Danial and 
Korsmeyer 2004). The BH3-only proteins members (Bid, Bad, Bim) selectively respond 
to specific death and survival signals. They can participate on the extrinsic and also 
on the intrinsic apoptotic pathway. For example, Bid is normally localized in the 
cytosol, but it is cleaved upon apoptotic stimuli (upon activation of surface death 
receptors) by caspase-8 and in the truncated form tBid is translocated into the 
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mitochondria. Through this process, the death receptor pathway activates the 
mitochondrial pathway (Li et al. 1998, Danial and Korsmeyer 2004).   
 Bid cooperates with other mitochondrial proteins in the mitochondria, which 
leads to the release of apoptogenic proteins, such as Bax and Bak. Upon interaction with 
BH3-only proteins through BH3 domain (Danial and Korsmeyer 2004), Bax and Bak 
undergo conformational change and oligomerization. They create pores, cause 
mitochondrial damage and release of cytochrome c and other apoptogenic proteins 
(Adrain et al. 2001, Wang et al. 2006, Cui et al. 2002). Bid seems to not be cleaved 
only by caspase-8, but also by other caspases, such as caspase-3. Bid may therefore 
serve as a general integrator and amplifier for many apoptotic signals (Wang et al. 
2006). 
 The activities of BH3-only proteins and proteins Bax and Bak can be neutralized 
by the antiapoptotic members of Bcl-2 family of proteins, Bcl-2 and Bcl-xL. These 
proteins do not affect the translocation of the BH3-only proteins to the mitochondria, 
but they block the oligomerization of Bax and Bak (Wang et al.  2006). 
 
1.1.7. Other proteins involved in apoptosis 
 
1.1.7.1. Apoptosis-inducing factor 
 
 Apoptosis-inducing factor (AIF) is a flavoprotein, which functions as 
an apoptotic effector. AIF is normally situated in the mitochondrial intermembrane 
space. The outer mitochondrial membrane becomes unspecifically permeabilized after 
induction of apoptosis (Daugas et al. 2000). AIF translocates from the mitochondria 
into the nucleus and causes chromatin condensation and DNA fragmentation (Wang et 
al. 2006). But AIF does not create apoptotic bodies in the cell. This intrinsic apoptotic 
signalling pathway is caspase-independent. The mitochondrion-nuclear distribution 
of AIF is blocked by Bcl-2 proteins (Daugas et al. 2000). 
 
 
 
 26 
1.1.7.2. Inhibitor of apoptosis protein 
 
 The inhibitor of apoptosis protein (IAP), containing BIR domain, regulates 
function of caspases. The N–terminal part of BIR domain binds to the substrate place 
of caspases, so that the protein substrate can not collocate to the active caspase (Fadeel 
and Orrenius 2005). IAP protein antagonizes caspase-3 activation (Hengratner et al. 
2000). 
 Several mechanisms, such as binding of Smac/Diablo control mammalian IAPs 
(Danial and Korsmeyer 2004). XIAP–associated factor 1 is a cytosolic protein, which 
antagonizes IAPs inhibition of caspases, and ensures the redistribution of XIAP (X-
linked IAP) (Fadeel and Orrenius 2005). 
 
1.1.7.3. Smac / Diablo 
 
 Smac/ Diablo is a mitochondrial protein released during apoptosis. Smac/ Diablo 
contains IAP binding motif and antagonizes IAP inhibition of caspases. For example, 
XIAP binds to the procaspase-9 matured form, which leads to the inhibition of caspase-
9 activity (Wang et al. 2001, Danial and Korsmeyer 2004). Smac displaces XIAP from 
the caspase-9, so XIAP does not repress active caspase-9 within the apoptosome 
anymore (Adrain et al. 2001). Smac releases from mitochondria into cytosol upon UV- 
and γ-irradiation, cytotoxic drugs, DNA damage and ligation of the CD95 death 
receptor. Translocation of Smac from mitochondria is blocked, when Bcl-2 is 
overexpressed. Unlike cytochrome c release is caspase-independent, Smac release 
depends on caspase activation (Adrain et al. 2001). 
 
1.1.8. Cytosine arabinoside 
 
 1-β-D-arabinofuranosylcytosine (AraC) is a pyrimidine antimetabolite, 
nucleoside analog (Fadeel and Orrenius 2005). AraC  is the most important agent used 
for induction of remission in acute leukemia in children and adults, because it effects 
antiproliferativelly (Iacobini et al. 2001, Mc Donald et al. 1991).  
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 AraC appears to be selectively incorporated into the nuclear, rather than 
mitochondrial DNA, so most probably does not alter mitochondrial functions. AraC 
probably incorporates into newly synthetized DNA of the cells, causes oxidative DNA 
damage and genotoxic stress, induces the formation of reactive oxygen species (ROS) 
and also DNA single-strand breaks. These processes lead to the increased p53 protein 
level, caspase-3 activation and to p53-dependent apoptosis. It is not clear, how AraC 
causes ROS generation. AraC increases ATP production and activity of cytochrome c, 
which might lead to ROS production (Fadeel and Orrenius 2005, Maňáková 2003). 
Besides this effect, AraC increases the activity of stress-activated protein kinases, 
such as Jun kinase, which promote apoptosis (Geller et al. 2001). 
 AraC induces apoptosis dose- and time-dependently also in healthy cells, it is 
therefore very toxic for dividing tissues. Myelosupression, gastrointestinal toxicity and 
neurotoxicity (cerebellar syndromes, myelopathy, peripheral neuropathy and 
encephalopathies) are the main side effects of AraC and the common and potential 
dose-limiting complications. Especially high doses can damage any part of the nervous 
system. These toxic effects of AraC on healthy cells happen probably through oxidation 
(Iacobini et al. 2001, McDonald et al. 1991, Geller et al. 2001).  
 Cell death caused by AraC can be abrogated by several anti-apoptotic agents or 
reduced by treatment with free-radical scavengers, such as dipyridamol, uric acid or 
vitamin E. Also antioxidants might have neuroprotective effects and could therefore be 
used to reduce neurotoxicity and DNA damage in AraC chemotherapy. Because cell 
death induced by AraC is p53 dependent, the toxicity of AraC is reduced in the 
depletion of p53 (Geller et al. 2001). 
 
1.2. Plant - derived polyphenols 
 
 Phenolic compounds in plants are their secondary metabolites, which are 
identified in many edible and nonedible plant materials, such as berries, fruits, 
vegetables, herbs, cereals, plant sprouts, seeds or tree materials. Their role in plants is to 
protect them from photosynthetic stress, reactive oxygen species, wounds and 
herbivores. They are important in normal growth development and defense against 
infection and injury. They have antinutritional effect, because they bind proteins and 
minerals and thus decrease absorption and digestability of food. They cause 
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adstringency of many fruits due to precipitating of salivary proteins (Yang et al. 2001, 
Kähkönen et al. 1999). Some of them, such as flavonoids give color to many flowers, 
fruits and leaves (Kähkönen et al. 1999). 
 The plant-derived polyphenols possess many biological effects, such as anti-
inflammatory, antibacterial, antiallergic, hepatoprotective, antithrombic, antiviral, 
vasodilatatory and  anticarcinogenic activity (Soobrattee et al. 2005, Yang et al.  2001). 
Many phenolics are potential therapeutic agents against a wide range of ailments, 
such as neurodegenerative diseases, cancer, diabetes, heart disease, cardiovascular 
dysfunction, inflammatory diseases and also aging. Their medicinal actions, such as 
antioxidant capacity, free radical scavenging, chelatation of redox active metal ions, 
modulation of gene expression and interaction with the cell signalling pathways might 
participate in their therapeutic activity (Soobrattee et al. 2005, Kähkönen et al. 1999). 
 The activities of plant-derived polyphenols very much depend on the structure. 
Conjugation system of bonds and the number and configuration of H-donating hydroxyl 
groups in the structure are of fundamental importance for the antioxidant function  
(Soobrattee et al. 2005). In the form of extracts, the activities can be supported from 
other extract components, such as sugars or acsorbic acid (Kähkönen et al. 1999). 
They can be used as natural antioxidants for the preservation and as prophylactic agents 
mainly in oxidative and nitrisative stress, which cause many acute and chronic clinical 
disorders (Soobrattee et al. 2005). Next to the chemical structure the availability and 
prevalence in food plants are important (Soobrattee et al. 2005).  
 
1.2.1. Biosynthesis 
 
 All plant phenolic compounds arise from the aminoacid phenylalanin or its close 
precursor shikimic acid. Phenylalanine ammonia-lyase (PAL), the main enzyme 
between primary (shikimate pathway) and secondary (phenylpropanoid) metabolism, 
is important for the formation (Herrmann et al. 1995).  
 The presence of polyphenols in different parts of plants is largely influenced 
by genetic factors and environmental conditions. For example, formation of flavones 
and flavonols strongly depends on light. The highest concentrations are therefore 
in leaves and outer parts of plants. Also other factors, such as germination, degree 
of ripeness, variety, processing and storage influence the content of polyphenols. 
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Many  of the phenolic compounds are very often glycosylated with  sugars, such as 
glucose, rhamnose, galactose and arabinose (Yang et al. 2001, Goldberg et al. 2003, 
Bravo et al. 1998).  
 
1.2.2. Bioavailability 
 
 The bioavailability of plant-derived polyphenols in vivo differs between different 
polyphenols, but it is quite low by many dietary polyphenols. They are extensively 
metabolised in vivo, mainly during transfer across the small intestine, by colonic 
microflora and in the liver. Their blood and tissue concentrations usually do not reach 
the levels used in in vitro experiments, thus they are usually not able to display the 
effects observed in vitro. Their activities, especially redox potentials are in this step 
very often alterated (Yang et al. 2001). 
 The main factors influencing bioavailability of polyphenols are chemical 
properties of polyphenols, deconjugation/ reconjugation in the intestine, intestinal 
absorption, mechanism of biotransformation and enzymes available for metabolism 
(Yang et al. 2001, Soobratte et al. 2005). 
 
1.2.3. Plant - derived polyphenols and cancer  
 
 It was proved, that cancer is a preventable and highly susceptible to dietary 
factors. Phenolic compounds are potential chemopreventive agents. Many of the 
molecular alterations associated with carcinogenesis occur in cell signalling pathways, 
that regulate cell proliferation and differentation. To the components of these pathways 
belong kinases, such as mitogen-activated protein kinases (MAPK) and protein kinase C 
(PKC), which contribute to homeostasis maintenance. Another component of signalling 
pathway is nuclear transcription factor NF- κB, that regulates the expression of various 
genes involved in inflammation and carcinogenesis. Abnormal activation or silencing 
of these kinases and factors can result in uncontrolled cell growth and therefore lead 
to malignant transformation (Fresco et al. 2006). 
 Polyphenols can activate cell death signals, induce apoptosis in precancerous 
and malignant cells and inhibite cancer development and progression by modulating cell 
signalling pathways and its components (Fresco et al. 2006). Other possible 
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mechanisms of anticarcinogenic effects can be inhibition of carcinogen uptake, 
inhibition of formation or activation of carcinogen, deactivation or detoxification of the 
carcinogen or preventing the carcinogen binding to DNA. Also antioxidant properties 
include scavenging oxygen radicals and inhibiting of arachidonic acid metabolism play 
an important role (Nichenametla and Taruscio 2006). 
 
1.2.4. Groups of plant - derived polyphenols and their biological 
effects 
 
 Polyphenols are very heterogenous group of compounds (Soobrattee et al. 
2005). They are complex substances with two or more phenolic rings joined together. 
Phenolic acids, flavonoids and stilbenes are the most abundantly occuring polyphenols 
in plants. Flavonoids and phenolic acids account for 60% and 30% respectively of total 
dietary polyphenols (Nichenametla and Taruscio 2006). The most abundant flavonoids 
are flavanols (catechins and proanthocyanidinins), anthocyanins and their oxidation 
products. The total daily intake is approximately 1g/day (Scalbert and Williamson 
2000). Natural polyphenols can range from simple molecules, such as phenolic acids, 
to highly polymerized compounds, such as tannins (Bravo et al. 1998).   
 
1.2.4.1. Phenolic acids and derivates 
 
 This group of plant phenols involves derivates of hydroxybenzoic and 
hydroxycinnamic acids, such as curcumin, caffeic, gallic and ferulic acid. They occur 
in food very often, mostly as esters. The general structures of hydroxybenzoic and 
hydroxycinnamic acids are in Figure 3. (Fresco et al. 2006).  
 The phenolic acids inhibit mutagenesis, have antimetastatic activity, modulate 
immune function and induce apoptosis. Besides their chemopreventive activities they 
can also promote carcinogenity via reactive oxygen species or tumor promoting activity 
(Nichenametla and Taruscio 2006).    
Caffeic acid is found in many fruits, such as apples, plums, tomatos and grapes 
(Soobrattee et al. 2005). Caffeic acid phenetyl ester (CAPE) exhibits dose-dependent, 
selective toxicity and growth supressive properties against cancer cells, but not against 
normal cells. CAPE supresses the motility of cancerogenic cells, which might be the 
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mechanism of metastasis inhibition (Nichenametla and Taruscio 2006). Other caffeic 
acid derivates inhibit several enzymes, such as 5-lipooxygenase or protein kinase C, that 
are involved in pathological processess, such as allergic diseases, inlammation, cataracts 
or neuropathies (Soobrattee  et al. 2005). 
 Ferulic acid is found in food sources, such as wheat bran (Bravo et al. 1998) and 
is known as a chemopreventive and antioxidant agent. It decreases the number of lung 
and skin tumors, but on the other hand its metabolite seems to be carcinogenic to liver. 
The carcinogenic and anticarcinogenic activity of caffeic acid may be dose specific. It is 
carcinogen at 2 %, tumor-promoter at 1% and anticarcinogenic at 0.05-0.5%  
(Nichenametla and Taruscio 2006). 
 Curcumin, found in Curcuma longa L. is the major yellow pigment in turmeric 
and mustard and is used as food preservative and yellow coloring agent for food, drugs 
and cosmetics (Yang et al. 2001). The chemical structure of curcumin is possible to see 
in Figure 3. (Yang et al. 2001). 
 
 
 
 a.           b.        c. 
 
Figure 3. Chemical structures of phenolic acids and derivates: a. hydroxybenzoic acid; 
b. hydroxycinnamic acid (Fresco et al. 2006); c. curcumin (Yang et al. 2001). 
 
1.2.4.2. Flavonoids 
 
 Flavonoids belong to the group of natural benzo-γ-pyran derivates. They appear 
as aglycones, glycosides and methylated derivates. In according to degree of central 
pyran ring oxidation, they can be divided into several groups: flavones, flavonols, 
flavonones, isoflavones, flavans, flavanols and anthocyanins. Polyphenolic biflavonoids 
are proanthocyanidins (Škerget et al. 2005). 
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 To flavanols (flavan-3-ols) belong catechins (epicatechin-3-gallat, 
epigallocatechin, epicatechin, catechin and epigallocatechin-3-gallat) abundant in tea, 
red wine, berries and chocolate (Nichenametla and Taruscio 2006). The chemical 
structure of epicatechin is in Figure 4. (Fresco et al. 2006). Catechins are able to induce 
apoptosis and have antiproliferative and growth controlling properties in cancerous cell 
lines. Catechins are involved in prevention of metastasis. They inhibit dose-dependently 
vascular endothelial growth factor-induced angiogenesis in human microvascular 
endothelial cells (Nichenametla and Taruscio 2006).  
 Catechins are potential agents against neurodegenerative diseases, because they 
decrease the expression of proapoptotic genes, such as Bax and others. Thus, they 
maintain the mitochondrial membrane integrity. They are also potentially effective 
against cancer, diabetic retinopathy and chronic inflammation. They supress 
angiogenesis by downregulating of VEGF production in tumor cells and inhibit 
capillary cell proliferation and blood vessel formation. They are also potent antioxidants 
in lipid systems (Soobrattee et al. 2005). Epigallocatechin has antioxidant, 
immunomodulatory and antimicrobial activity (Nichenametla and Taruscio 2006). 
 
 
           
 
 
                
Figure 4. Chemical structure of epicatechin (Fresco et al. 2006). 
 
 Next to flavanols belong to this group of polyphenols flavonols, such as 
quercetin, myricetin and kaempferol (occurs as glycoside in fruits). Glycosidic form 
of quercetin is rutin (Nichenametla and Taruscio 2006). The chemical structure 
of quercetin is in Figure 5. (Fresco et al. 2006, Škerget et al. 2005). 
 Quercetin inhibits cell proliferation, cancer cell growth and cessation of cell 
cycle. Kaempferol reduces estrogen receptor-positive breast cancer cells and functions 
as growth inhibitor. But these functions of kaempferol depend on concentration, 
because it enhances cell growth at low concentration (1-10 μM) by acting as an estrogen 
receptor agonist and enhancing DNA synthesis (Nichenametla and Taruscio 2006). 
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 Anticancerogenic activity of flavonols may be due to their antioxidant acivity. 
Quercetin and kaempferol increase levels of glutathione, a natural antioxidant. 
Quercetin, myricetin and kaempferol also induce apoptosis by induction of caspase-3, 
procaspase-9, elevation of reactive oxygen species and release of mitochondrial 
cytochrome c. Quercetin, myricetin and kaempferol have effectively supressed the 
activity of several cell proliferative enzymes, such as cyclooxygenase-2, topoisomerases 
I and II and ornithin decarboxylase (Nichenametla and Taruscio 2006). 
 
   
 
 
 
 
Figure 5. Chemical structure of quercetin (Škerget et al. 2005).  
 
 Another group of flavonoids flavones are represented by luteolin and apigenin. 
To the group of isoflavones belong genistein and daidzein, which mostly occur 
in soybeans and are considered as phytoestrogens (Yang et al. 2001). They have been 
suggested to protect against hormone-related types of cancer, such as breast or prostate, 
and menopausal symptoms (Soobrattee et al. 2005). The chemical structure of apigenin 
is in Figure 6. (Fresco et al. 2006). 
 
 
 
 
 
 
Figure 6. Chemical structure of apigenin (Fresco et al. 2006). 
 
 Anthocyanins, such as cyanidin are water-soluble pigments, which have 
antioxidant activity and cancer preventive activity. Berry extracts containing a lot 
of anthocyanins have differential effects on normal and cancerous cells. For example, 
grape seeds induce cytotoxicity in several types of cells, but increase the viability 
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in normal human cells (Nichenametla and Taruscio 2006, Fresco et al. 2006). 
The structure of cyanidin is in Figure 7. (Fresco et al. 2006). 
 
  
 
 
 
 
Figure 7. Chemical structure of cyanidin (Fresco et al. 2006). 
 
1.2.4.3. Stilbenes 
 
 Most stilbenes act as antifungal antialexins, compounds, which are usually 
synthesized only in response to infection or injury. To this group belongs for example 
resveratrol, which is present in grapes, wine and peanuts (Yang et al. 2001). 
The chemical structure of resveratrol is in Figure 8. (Fresco et al. 2005). 
 Stilbenes inhibit cellular events associated with carcinogenesis, including tumor 
initiation, promotion and progression, so they are chemopreventive and cytotoxic. 
Resveratrol also inhibits the expression of vascular endothelial growth factor and thus 
tumor neovascularization. But it does not distinguish between physiological and 
pathological angiogenesis, so it delayes wound repair (Nichenametla and Taruscio 
2006). 
 Resveratrol inhibits free radical formation and effects production and activation 
of several enzymes. For example it decreases activity of ornithine decarboxylase, which 
is enhanced in cell cancer proliferation. Resveratrol induces apoptosis and increases the 
expression of p53 by enhancing the Bax activity (Nichenametla and Taruscio 2006). 
 
 
 
 
 
 
Figure 8. Chemical structure of resveratrol (Fresco et al. 2006). 
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1.2.4.4. Tannins, lignans and coumarins 
 
 The best known hydrolyzable tannin is tannic acid. Tannins can form insoluble 
complexes with carbohydrates and proteins. This function of tannins is responsible for 
the adstringency of tannin-rich food, because of the salivary proteins precipitation 
(Bravo et al. 1998). The structure of tannic acid is in Figure 9. (Fresco et al. 2006). 
 
 
 
 
 
 
 
 
 
Figure 9. Chemical structure of tannic acid (Fresco et al. 2006). 
 
 Lignans, such as sesamin, enterodiol and enterolacton, have antioxidant 
properties. They function as phytoestrogens, which potentially decrease the mammary 
tumorigenesis (Yang et al. 2001). The structure of sesamin is in Figure 10. (Fresco et al. 
2006). 
 
 
 
 
Figure 10. Chemical structure of sesamin (Fresco et al. 2006). 
 
 Coumarins, such as esculetin have antioxidant properties (Fresco  et al. 2006). 
The chemical structure of coumarin is in Figure 11. (Fresco et al. 2006). 
 
 
 
 
Figure 11. Chemical structure of coumarin (Fresco et al. 2006). 
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1.2.5. Polyphenols in different plants 
 
1.2.5.1. Basil (Ocimum basilicum) 
 
 Basil is an annual plant, belonging to the Lamiaceae family. The aromatic 
character of this plant depends on the major chemical compounds of essential oils 
primarily consisting of monoterpenes and phenylpropanoids (Miele et al. 2001). 
 Generally, the essential oil of Ocimum basilicum leaves, stems and flowers 
ranges from 0.07 to 1.92 % in dry herbage. The main components of essential oil are 
monoterpnene alcohol (Lewinsohn et al. 2000) linalool (30-70%), methylchavicol (0.1-
70%), eugenol (8-30%) and methyleugenol (1-91%). To other components belong delta-
cadinene, alpha-pinene, alpha-humulene, camphene, eucalyptol, isobornyl acetate, 
camphor and trans-caryophyllene  (Zheljazkov et al. 2008). 
 There are big differences in the content of essential oils between the wild and 
cultivated type of basil. They consist in different environmental conditions, such as 
temperature, length of summer, soil characteristics, number of cut and production 
system. Stress (chemical elicitators, heavy metals, cutting) causes enhancement 
of polyphenol production and accumulation (Zheljazkov et al. 2008). 
 The essential oil has a pleasant aroma and antimicrobial and insecticidal activity, 
and is therefore used as aromatic agent to food, culinary (leaves), pharmaceuticals, 
cosmetic, aromatherapy industries and  natural therapies (Zheljazkov et al. 2008). 
Linalool is used in domestic products, such as soaps and shampoos. Camphor is used as 
a moth repellent (Miele et al. 2001). Eugenol is used in dentistry as an antiseptic and 
analgesic agent, but it is in a dose-dependent manner genotoxic (Maralhas et al. 2006). 
 The essential oil has antioxidant, antimicrobial, free radical scavenging, 
inhibitory lipid peroxidation, spasmolytic, carminative, hepatoprotective and antiviral 
properties. Minor basil oil constituents delta-cadinene, 3-carene, alpha-humulene, citral 
and trans-cyrophyllene have antileishmanial activity and in the same time do not have 
cytotoxic effect on mammalian cells, except citral  (Zheljazkov et al. 2008). 
 The major antioxidant compound of Ocimum basilicum is rosmarinic acid. 
(Jayasinghe et al. 2003), which has suppressive effect on mesangioproliferative 
glomerulonephritis (proliferation of mesangial cells and glomerular matrix expansion) 
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(Makino et al. 2002). The antioxidant activity of basil is concentration-dependent 
(Gülçin et al. 2007).  
 The essential oil of basil has antiproliferative effect against epidermal carcinoma 
and murine leukemia (Manosroi et al. 2006). Basil extract supresses carcinogenesis and 
can act as a protective agent, so it might be used in cancer treatment (Aruna et al. 1990).  
 
1.2.5.2. Laurel (Laurus nobilis) 
 
 The laurel plant is an evergreen shrub or tree with aromatic smell from the 
family Lauraceae. Its leaves and essential oil have been traditionally used as condiment 
and against cancer, bronchitis, dermatitis, digestive problems and anxiety (Škerget et al. 
2005, Conforti et al. 2006, Ferreira et al. 2006, Longo et al. 2005). Bay leaves are used 
as food preservatives, due to their antimicrobial and insecticide activities, because 
of aroma also in cosmetic industry (Longo et al. 2005). The essential oil exhibits also 
significant analgesic, anti-inflammatory and sedative effect. The sedative effect may be 
related to the presence of eugenol and methyleugenol, which possess anesthetic and 
muscle relaxant activities. β-pinene, α-pinene and sabinene possess anti-inflammatory 
activity (Sayyah et al. 2003). 
Laurus nobilis essential oil has cytotoxic effect on mellanoma cells, renal cell 
carcinoma, breast cancer cell line, prostate carcinoma. This oil inhibits human tumor 
cell growth (Loizzo  et al. 2007). The main component of essential oil prepared from 
bayleaves Laurus nobilis is 1, 8-cineole. This substance induces apoptosis and thereby 
supresses growth specifically in human leukemia cells in dose- and time-dependent 
manner (Moteki et al. 2002). Sesquiterpene costunolide from the essential oil has strong 
growth inhibitory, pro-apoptotic effect against human leukemia cells. This activity 
increases with concentration (Komiya et al. 2004). 
  The leaves oil contains cinnamtannin B-1, a proanthocyanidin, which is 
a radical scavenger with a great antioxidant activity (Ben Amor et al.  2007). 
Cinnamtannin B-1 enhances caspase-3 activity and causes apoptosis in tumoral cells, 
but not in normal cells. The reason for different effect of cinnamtannin B-1 in apoptosis 
in normal and tumoral cells has not been fully investigated. The concentration does not 
influence this fact (Bouaziz et al. 2007). Polyphenolic flavonol aglycones isoquercetin 
and kaempferol are responsible for the exhibited antioxidant activity (Soobrattee et al. 
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2005). Isoquercetin from the leaves possesses very high alkyl peroxy radical scavenging 
activity (Kang et al. 2002). Secondary metabolites, contained in laurel leaves, 
eventually in fruits are sesquiterpenes, such as santamarine, reynosine and costunolide, 
which have antimicrobial, immunomodulating and cytotoxic activities in human 
leukemia cells (Matsuda et al. 2002).   
 
1.2.5.3. Juniper (Juniperus communis)  
 
 Juniperus communis from the family Cupressaceae is an evergreen, aromatic 
shrub or tree. Seeds, dried leaves and fruits, in form of extract, are traditionally used 
to treat bronchitis, common cold, nose bleed, hypertension, inflammation, 
as expectorans, diuretics and for rheumatic symptoms. Nowadays juniper is used as 
an aroma in foods, drugs and cosmetics (Emami et al. 2007). All organs of this plant 
contain essential oil, but it is obtained mainly from the berries, needles and branches 
(juniper foliage). The oil content is around 0,2-3,4%, depending on geographic location, 
altitude, degree of ripeness, and other factors (Barjaktarović et al. 2005). 
 Juniperus communis grows widely in both hemispheres, primarily in lower 
elevations. The main content of leaves essential oil are monoterpenes, such as alpha-
pinene (40-60%), sabinene (1-10%), camphene, beta-pinene, myrcene, alpha-
phellandrene, 3-carene and terpinen-4-ol (Filipowicz et al. 2006). The juniper essential 
oil (Juniper aetheroleum) from juniper berry contains mainly monoterpenes (58-85%), 
such as alpha-pinene (10-76%, mostly around 30%), beta-pinene (around 18%), 
sabinene (1-28%, mostly around 15%), beta-myrcene, terpinen-4-ol and sesquiterpenes 
(Pepeljnjak et al. 2005, Barjaktarović et al. 2005). To the flavonoids contained 
in juniper belong catechins and epitcatechins (Iida et al. 2007). 
 The methanol extract from fruits and leaves of Juniperus communis possess 
antioxidant acitivity, even higher than alpha-tocopherol (Emami et al. 2007). 
Juniper berry extract is able to kill a large amount of liver and colon carcinomas 
(Bayazit et al. 2004) and decreases the growth of breast cancer cells (Slambrouck et al. 
2007). Decoction from juniper berries decreases glycemic levels in normoglycemic due 
to increasing of peripheral glucose consumption (De Medina et al. 1994). Juniper also 
possess antimicrobial activity against dermatophytes, Gram-positive and Gram-negative 
bacterial species (Pepeljnjak et al. 2005). 
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2. AIM OF STUDY 
 
 Plants and herbs are used in folk medicine against many human diseases, 
including cancer, for a long time. Previous studies showed that plant-derived 
polyphenols have many properties, including antioxidant and anticancerogenic 
activities, which can effect apoptosis. They can directly interact with specific steps 
and/or proteins regulating apoptotic process in different ways depending on their 
concentration, the cell system, the cell type or the stage of pathological process 
(Giovannini et al. 2007). 
 The aim of the experimental part of this work was to examine the activities 
of several plant extracts containing polyphenols, concretely their effect on cell viability. 
Several studies comparing the effects of plant extracts and isolated phenolic compounds 
from these extracts have proven, that the whole extract has much higher activities than 
the individual compounds. It is possible, that the compounds within the extract have 
synergistic influence on each other (Giovannini et al. 2007).    
 The experiments were performed on the SH-SY5Y neuroblastoma cells, 
which are human neuroblast highly metastatic cancer cell line. Previously, these cells 
were used for example in experiments involved in the Parkinson’s disease research 
(Maňáková et al. 2003), in the examination of nicotinic receptors in these cells (Ridley 
et al. 2001) or in the experiments examining effect of cytarabin, resveratrol and 
kurkumin on apoptosis (Lantto 2006). In the experiment were used extracts from laurel, 
juniper and basil, which were prepared at the University of Helsinki, Department 
of Pharmaceutical biology (Hinneburg et al. 2006) 
 To the used methods belong Western blotting analysis, MTT and LDH assay. 
The level of p53 protein in cells was measured in Western blotting analysis. The cell 
viability was examined in MTT and LDH assay. MTT assay measures the amount 
of formazan created from MTT by reducing enzymes in the living cells. LDH assay 
measures the enzyme lactate dehydrogenase, which is produced in the damaged cells. 
The aim of study in MTT and LDH assays was to compare the effects, production 
of enzymes, of different extract concentrations after the same time of incubation. 
The main goal in Western blotting analysis was to show how the level of p53 protein 
(commonly used marker of apoptosis) is changing upon effect of one extract 
concentration depending on incubation time.   
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3. MATERIALS AND METHODS 
3.1. Principles of methods 
3.1.1. Cell viability assays 
3.1.1.1. MTT assay 
 
 MTT is a laboratory test and a standard colorimetric assay. This method is used 
to measure cell viability and proliferation, cell population’s response to external factors 
and to screen the effect, eventually cytotoxicity of anticancer drugs. It is based on the 
reduction of tetrazolium salt (MTT). 
 Pale yellow MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) is a water soluble dye, which is reduced by metabolically active cells by their 
dehydrogenase enzymes. This reaction leads to the creation of reducing equivalents, 
such as NADH and NADPH. In principle, it is a NADH dependent reduction. MTT is 
reduced to water insoluble purple to dark blue crystalic formazan. The amount 
of formazan generated per cell depends on the level of energy metabolism in the cell, 
in otherwords on cell viability (Mosmann 1983). Formazan product is only partially 
soluble in medium (Mosmann 1983), so a solubilization solution, either dimethyl 
sulfoxide (DMSO) or detergent sodium dodecyl sulfate solution in dilute hydrochloric 
acid is added to dissolve formazan product into a colored solution. The absorbance 
of colored formazan solution can be measured and quantified at a certain wavelength 
(usually between 500 and 600 nm) at a spectrophotometer (Mossmann 1983). 
 The low absorbance means absence of cells or decreased cell viability. Higher 
absorbance means an increase in cell proliferation. Measuring of the absorbance allows 
to quantify change in the rate of cell proliferation. The linear relationship between cell 
number and signal produced is established for each cell type.  
 Reduction of MTT, in other words cleavage of the MTT ring, takes places only 
in active living cells, in which reductase enzymes and dehydrogenases are active. 
The amount of created formazan is directly related to the number of viable cells. 
Increased viable cell number results in increased amount of formed MTT formazan and 
an increase in absorbance. When the amount of formazan produced by treated cells is 
compared with the amount of formazan produced by untreated cells, the effectivness 
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of the agent in causing cell death can be deduced from a dose-response curve. 
 This method does not detect death cells. The cell population should be homogenous 
(Mosmann 1983). 
 
3.1.1.2. LDH assay 
 
 LDH test is a fluorometric assay and a cell viability test, based on the fact, that 
damaged cells have decreased integrity of cell membrane, which allows the entrance 
of enzym lactate dehydrogenase (LDH) outside the cell. LDH is an oxidoreductase 
which catalyzes the interconversion of lactate and pyruvate. The LDH assay is based 
on the reduction of iodonitrotetrazolium salt (INT) in a NADH-coupled enzymatic 
reaction to red colored formazan. Formazan exhibits an absorption maximum at 492 nm 
and can be measured colorimetrically. The intensity of the formed red or purple color is 
increased in the presence of increased LDH activity (Larsen 2005). 
  
Scheme of the reaction catalysed by LDH: 
 
NAD
+
   +   lactat   →    pyruvat   +   NADH 
 
NADH   +   iodonitrotetrasolium-diaphorase  →    NAD+   +   formazan 
 
3.1.2. Western blotting 
 
 Western blotting is a modern technique, which is used for analysis and 
characterization of proteins, for purifying and identifying of biochemicals on the basis 
of charge, size and conformation, and to determine their molecular sizes (weights). 
Purity is indicated by the number of stained bands in the electropherogram. One band 
usually means, that only one detectable component is present. In this case the sample is 
homogenous or „electrophoretically pure“. Two or more bands indicate, that the sample 
contains more components, contaminants or inpurities and is therefore heterogenous. 
Sometimes there is just one component, but there are more bands found. This can 
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happen, when the component degrades during electrophoresis. The principle of this 
method is the transfer and detection of proteins that react with antibodies (Boyes 2000).   
Western blotting has several steps. The first step is sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). SDS-PAGE serves mainly to the 
fractionation of protein mixture. The samples have to be denaturated in order 
to fractionate proteins properly (Boyes 2000). The protein samples are transferred into 
the wells of polyacrylamide gel. The polyacrylamide gels are prepared by the free 
radical polymerization of acrylamide and the cross-linking agent N,N‘-methylene-bis-
acrylamide. Chemical polymerization is controlled by an initiator-catalyst system, 
ammonium persulfate-N,N,N‘,N‘-tetramethylenediamine (TEMED). Standard gel 
for protein separation contains 7,5 % polyacrylamide and is used to identify proteins 
with molecular size 10,000 to 1,000,000 daltons with the fact, that best results are 
reached in the range of 30,000 to 300,000 daltons. The resolving power and molecular 
size range of a gel depend on the concentration of acrylamide and bis-acrylamide. 
Using low concentrations a gel with larger pores is created, which is used to analyse 
higher-molecular-weight biomolecules. Higher concentration of acrylamide gives the 
gel with smaller pores, therefore used to analysis of lower-molecular-weight 
biomolecules (Boyes 2000). 
It is possible to use prepared, so called pre-cast gels or to prepare our own gel. 
In this experiment the gel was prepared. It is so called slab gel. The polyacrylamide slab 
is prepared between two glass plates, that are separated by spacers. The spacers allow 
a thickness of 0.5 to 2.0 mm, which is appropriate for analytical procedures. Slab gels 
are usually 8x10 cm or 10x10 cm big. The plastic combs inserted into the top of the slab 
gel create wells. There are usually 10 or 12 wells created. After the gel is polymerized, 
the comb is removed and the wells should be rinsed with electrophoresis buffer 
to remove salt and unpolymerized acrylamide. The gel plate is clamped into place 
between two buffer reservoirs and a sample is loaded into each well (Boyes 2000).  
During SDS-PAGE the proteins are in the electric field. Voltage stays constant 
during electrophoresis. The movements of charged particles through the gel depend 
directly on the electric field and charge and inverselly on the viscozity (Boyes 2000). 
 To the main components of the SDS buffer belong SDS and mercaptoethanol. 
The detergent SDS disrupts secondary, tertiary and quarternary structure to produce 
linear polypeptide chains coated with negatively charged SDS molecules. 
Mercaptoethanol assists in protein denaturation by reducing all disulfide bonds. 
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The detergent binds to hydrophobic regions of the denaturated protein chain. The bound 
detergent molecule carrying negative charges mask the native charge of the protein. 
Thus, a polypeptide chain of a constant charge ratio and uniform shape is prepared. 
The electrophoretic mobility of the SDS-protein complexes depends very much on the 
molecular size. The larger molecules are going slower through the gel because of gel 
sieving, whilst small molecules have greater mobility (Boyes 2000).  
 After the first step, proteins are deeply embedded in the gel, so they are not 
accessible for analytical reagents. Thus, in the second step proteins separated by SDS-
PAGE are transferred (blotted) from the gel to support matrix, which can be nylon, 
polyvinyl-difluoride or nitrocellulose membrane. The nitrocellulose membrane is the 
most used. The membrane strongly binds and immobilizes proteins. Binding of proteins 
to nitrocellulose membranes is noncovalent, mostly hydrophobic (Boyes 2000). 
 Effective transfer is reached by using of an electrophoretic blotter. A sandwich 
of filter paper, gel, membrane and special sponges is prepared in a cassette, which is 
placed between platinum electrodes. An electric current is passed throught the gel and 
causes the electrophoresing of proteins out of the gel onto the membrane. The migration 
of molecules is influenced by electric field (Boyes 2000). The protein blots are on the 
membrane better accessible for chemical or biochemical reagents, so in this form ensure 
further analysis of proteins, which have specific structure and function. Highly specific 
and sensitive immunological detection technique for analysis is called Western blotting 
(Boyes 2000).  
 After blotting it is necessary to probe the protein bands and detect a specific 
protein or group of proteins among the blots, in other words to visualize the specific 
protein blots. Specific identification is based on immunology, which means antigen-
antibody interactions. Protein binding sites on the membrane, which are not occupied 
by blotted proteins, have to be blocked before detection. The reason is that antibodies 
used for detection are also proteins, so they could interfere with these proteins. Protein 
binding sites still remaining on blotted membranes can be blocked with solution 
of casein, which is the major protein in milk. Milk solution is the most used blocking 
buffer.  
 When all protein binding sites of the blotted membrane are occupied, it can be 
treated with analytical reagents for detection of specific proteins. The blotted membrane 
is incubated with so called primary antibody, antibody, which is specific for protein 
of interest. The primary antibody creates with the protein of interest antigen-antibody 
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complex. However, the interaction between protein and antibody usually does not create 
any visible signal. The blot is therefore incubated with a secondary antibody, which is 
directed against general class of primary antibody. For example, if the primary antibody 
was prepared in rabbit serum, the secondary antibody will be anti-rabbit IgG, usually 
from a goat or a horse. The secondary antibody is labeled (conjugated), so the interacion 
between primary and secondary antibody produces visible signal. Secondary antibody is 
usually tagged with an enzyme, usually horseradish peroxidase (HRP). When the treated 
blot is incubated in a substrate solution, the conjugated enzyme catalyzes conversion 
of the substrate into a visible product, that precipitates at the blot site. The protein is 
situated on the place, where the colored band is present (Boyes 2000). 
 The reaction catalyzed by conjugated enzymes is: 
4-chloro-1-naphtolreduced + H2O2 → 4-chloro-1-naphtoloxidized + H2O2 + 1/2 O2  
Western blotting, also called immunoblotting assay of proteins, have many advantages, 
such as small reagent volumes, short processing time, relatively inexpensive equipment 
and ease of performance (Boyes 2000). 
 
3.1.3. β-actin 
 
 Beta-actin is one of six different actin isoforms which have been identified 
in humans. Beta-actin belongs to the non-muscle cytoskeletal actins. Actins are highly 
conserved proteins, that are involved in cell motility, structure and integrity. Beta-actin 
is a constituent of filaments attached to the nuclear pore complexes and extending into 
the nucleus (Pederson et al. 2005). 
 Beta-actin is implicated in the regulation of cell spreading and membrane 
organisation. The intracellular location of beta-actin mRNA has been shown to be 
regulated by growth factor stimulation of signal transduction pathways (Gunning et al. 
1997). 
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3.2. Methods 
3.2.1. Cell culture 
 
The SH-SY5Y chemosensitive neuroblastoma cells were used in the 
experiments. Stock cultures of SH-SY5Y human neuroblastoma cells were maintained 
in a DMEM: F12 (1:1) (Gibco) modified medium supplemented with 1% of non-
essential amino-acids (NEAAs, 100x) (Gibco), 15% foetal bovine serum (FBS) (heat-
inactivated +56 °C, 30 minutes) (Gibco), Penicillin-streptomycin (170 U/ ml penicillin 
G sodium, 170 μg/ ml streptomycin sulfate) (Gibco). Cultures were seeded into 75 cm2 
standard tissue culture plastic flasks containing 20 ml of supplemented medium and 
maintained at 37°C in 5% CO2 humidified air. Stock cultures were passaged 1:2 to 1:4 
weekly and fed every other day. 
 
3.2.1.1. Preparing of a new cell culture 
 
The cell suspension was freezed in liquid nitrogen. The new cell culture was 
prepared by melting of cell suspension in vial in water bath for 1-2 minutes. Then the 
cell suspension was added into 40-50 ml of medium in  a 75 cm
2
 flask. After 6-8 hours 
the medium was changed. 
 
3.2.1.2. Preparing of a cell subculture 
 
 The old medium was sucked out for binding assays. The SH-SY5Y cells were 
detached by adding 2,5 ml of Trypsin-EDTA (pH 7,4) and incubated for 3 minutes at 
37 °C to loosen cells. 10 ml of medium was added and the cells were thus transferred 
into a falcon tube. The suspension was then cetrifuged at 500 x g, 3 minutes, 20 °C to 
separate the cells from medium. After that the supernatant was removed.  
 The cells with confluency 90-95 % were used for preparing the experiment. 
The cells were suspendend in 1 ml of medium. 10 μl of suspended cell suspension was 
added into 990 μl of medium in the tube and the cells were counted in Bürker chamber 
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in 5 patches, which did not neighbour with each other with their sides, only with their 
corners. 
  
3.2.2. Plant extracts 
 
In the experiments the extracts from laurel, juniper and basil were used. The aqueous 
extracts were prepared by water extraction. The essential oils were removed 
by hydrodistillation. The content of total phenols in the extracts is in the Table 2. 
(Hinneburg et al. 2006). 
 
Species Total phenols (mg/g) 
Laurel (Laurus nobilis L.) 92,0 ± 2,45 
Basil (Ocimum basilicum L.) 147 ± 1,60 
Juniper (Juniperus communis L.) 18,5 ± 0,62 
Table 2. Content of total phenols in the extracts from juniper, laurel and basil 
(Hinneburg et al. 2006). 
 
3.2.3. Cell viability assays 
3.2.3.1. Cell culture for cell viability assays 
 
 For the cell viability assays the cells were seeded in 96-well plates in 200 μl 
of medium with 6 x 10
4
 cells per each well. For measuring background six wells were 
filled only with medium. Residual wells were filled with sterile H2O. The cells needed 
some time to become confluent, to recover from handling and to attach to the wells, 
thus they stayed in the incubator at 37°C and 5% CO2 over night. The old medium was 
removed and 150 μl of fresh medium containing 5% of FBS was added into the wells.  
 The cells were treated with extracts from juniper, laurel and basil. The stock 
solutions with concentration 30 mg/ml were prepared by dissolving 30 mg of each 
extract in 1 ml of medium. New solutions were prepared from the stock solutions 
by dissolving in medium, in a way, that by adding of 10 μl of these new solutions to the 
150 μl of medium, the concentrations were in sequence 2; 0,5; 0,1; 0,05 and 0,01 
mg/ml. In according to reach homogenity within the wells, the plate was shaked after 
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adding of extracts. AraC in the concentration 100 μM has been in the sixth column. 
Only cells in 150 μl of medium without extract (serve as a control) have been in the 
seventh column. Only 150 μl of medium has been in the eigth column. The cells were 
exposed to the extracts for 12 hours in the incubator at 37°C and 5% CO2. After 12 
hours 50 μl of medium without cells was transferred from the transparent plate into 
a new 96-well white-walled plate.   
 
3.2.3.2. MTT assay  
  
 MTT solution in concentration 5mg/ml was prepared by dissolving in HBSS 
solution (Hank’s balanced salt solution, 5,36 mM KCl; 441 μM KH2PO4; 137 mM 
NaCl; 4,17 mM NaHCO3 and 337 μM Na2HPO4, pH 7,4) and 10 μl of this solution was 
added to the rest of the fluid in the old plate. The final concentration of MTT in each 
well was thus 0,5 mg/ml. Gentle shaking is necessary to mix the MTT into media. 
 Incubation with MTT solution lasted 2,5 to 3 hours at 37°C until the purple 
precipitate was visible. Afterwards the medium was carefully removed in the corners 
of the plate to avoid removing of blue crystals on the well’s bottom. Then 200 μl 
of DMSO (dimethyl sulfoxide) was added into every well and resuspended until the 
blue crystals fully dissolved. At the end, the absorbance, otherwords optical density was 
measured in a microtiter plate reader (Bio-Rad, model 550, Japan) at the wavelength 
550 nm with the reference filter set to 655 nm.  
 
3.2.3.3. LDH assay 
 
 The LDH assay kit was used for the LDH test and the assay was performed 
following manufacturer’s instructions. The 96-well white-walled plate with 50 μl 
of medium in each well was equilibrated at RT for 20-30 minutes. Then 50 μl of 
CytoTox-One reagent was added into each well. The plate was wrapped into aluminium 
folia and shaked for 10 minutes at 300 rpm, followed with further 20 minutes of 
incubation at RT.  
 After 30 minutes 25 μl of Stop solution was added (in the same order as addition 
of reagent). The Stop solution stops the reactions and stabilizes the fluorescent signal. 
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The adding of CytoTox reagent had to be quick, because the reagent is sensitive to the 
light. Also adding of Stop solution was quick in according to react in all wells for the 
same time.  
 After adding the Stop solution, the plate was shaking for a few seconds at 
300 rpm and right after that the fluorescence (the amount of created LDH) was 
measured spectrophotometrically on Varioskan machine with excitation 560 nm and 
emission 590 nm. It was necessary to avoid air bubbles while pipetting (using needles 
to explode them) and keep the plate in dark (aluminium folia) the whole time after 
adding the reagents until measuring. The measuring should be provided after adding the 
Stop solution as soon as possible. 
  
3.2.4. Western blotting 
3.2.4.1. Cell culture for Western blotting 
 
 The treatment of cells for Western blotting was similar to the one for cell 
viability assays. After counting of cells,  2,5 x 10
6
 cells were cultured in the sterile, 
plastic plates in 5 ml of medium. After 18-24 hours of incubation at 37°C and 5% 
of CO2, the cells were treated with plant extracts from basil and laurel, concretelly basil 
was used in the concentration 0,5 mg/ml and laurel 0,1 mg/ml. These extracts were the 
same as for cell viability tests.   
 This experiment was examining time response. All cells were treated with the 
same concentration of plant extract, but they differed in the time of exposure to the 
plant extract. After certain time the plates with cells were taken out of the incubator, 
put onto the ice. The medium was removed away and 2,5 ml of ice cold physiological 
solution (PBS, phosphate buffered saline, 137 mM NaCl; 2,7 mM KCl; 7,9 mM 
Na2HPO4 and 1,5 mM KH2PO4) was added. After the washing of cells with PBS two 
times, 1 minute each washing, the cells were collected by scraping into 1,25 ml of ice-
cold PBS. The tubes with cells were centrifuged (Eppendorf 5415D, Germany) at 4°C 
and 5000 x g for 5 minutes. The supernatant was removed and the cell pelets were 
stored at –80°C. 
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3.2.4.2. Protein extraction and BCA protein assay 
 
 The proteins were extracted from cells by a lysis buffer (20 mM N-2-
hydroxyethylpiperazin-N1-2-ethanesulfoc acid (HEPES); 20% glycerol; 500 mM NaCl; 
1,5 mM MgCl2; 0,2 mM EDTA and 0,1% Triton X-100) with Complete Mini Stock 
solution protease inhibitor (Roche). The cells were then incubated on ice for 30 minutes. 
After that the tubes with samples were briefly shaked on Vortex and then sonicated 
3 x 10 seconds (Rinco Ultrasonics, Switzerland). In order to remove DNA and pieces 
of cell membrane from the protein sample, the samples were centrifuged (Eppendorf 
5415D, Germany) at 4°C and 16 100 x g for 15 minutes. The supernatant was then 
trasnferred into new tubes.   
 The protein samples were diluted in the rate of 1:10 with the EMSA buffer and 
10 μl of each protein sample was transferred twice behind the BSA standards. 
200 μl of a solution, created by mixing of two liquides-reagents A and B (in the rate 
50:1), acids from BCATMProtein Assay Kit, Pierce, was added into each well. 
After 30 minutes of incubation in the folio at 37°C, the plate was cooled down. Then the 
absorbance, and thus protein concentration, was measured on spectrophotometer (Bio-
Rad, malli 550, Japan) at 550 nm of wavelength. 
 Due to the BSA standards the protein concentration was measured, and it was 
counted, how much of the sample is necessary to prepare a loading sample for Western 
blotting. In this experiment 20 μg of protein per well was used. The pipetting volume 
was 20 to 30 μl in according to the ascertained protein content (when the protein content 
was to low, the loading volume was smaller). In according to get comparable results, 
all the samples contained the same amount of protein, which was reached by dilution 
of the samples with higher concentration with lysis buffer. Before loading and starting 
the western bloting, 4x electrophoresis sample buffer (loading buffer) was added to the 
protein samples. The loading buffer (125 mM Tris (pH 6,8); 50% glycerol; 4% 
natriumlaurylsulphat (SDS, sodium dodecyl sulphate); 10% 2-merkaptoethanol and 
0,02% bromophenol) denaturalizes the proteins and dilutes the protein sample in the 
rate 1:3. The whole time the samples had to be in ice. 
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3.2.4.3. SDS-PAGE 
 
 The protein samples were loaded into the prepared sodium laurylsulphat-
polyacrylamid gel (SDS-PAGE, sodium dodecyl sulphate polyacrylamide gel 
electrophoresis). The gel contained two parts. The stacking (upper) gel containing 5% 
of polyacrylamide was used to concentrate the sample and to make thin starting layer 
for proteins before they enter the separating gel. The separating (lower) gel containing 
12% of polyacrylamide was used to separate the proteins in according to their molecular 
weight. At first the resolving gel was prepared. It takes about 45 minutes until the gel 
stiffts. During stiffting, above the gel there was destilled water, which was removed 
when the stacking gel was prepared. The gel could be used immediatelly after the 
preparation or it could be stored in the refrigerator over night, covered with a moist 
paper and plastic folia. 
 Also Prestained protein MW marker, Fermentas (5μl/ well) with the molecular 
weight 10,000-70,000 was loaded into the gel. This marker is necessary to identify the 
searched proteins in according to their molecular weight on the membrane in the latter 
phase of Western blotting and for detection (especially when there are two or more 
proteins searched in one experiment). Electrophoresis proceeded in the electrophoresis 
buffer (25 mM Tris; 192 mM glycine and 0,1% SDS) at Bio-Rad (PowerPac HC, USA) 
machine at constant voltage 120 V and 25-30 mA per slab gel approximatelly for 1,5 
to 2 hours, until the bromophenol blue marker dye reaches the bottom of the gel. 
The speed depends on voltage. When the voltage is higher, the marker and samples 
wander through the gel quicker. 
 
3.2.4.4. Transfer of proteins onto membrane  
 
 The proteins were transferred from the gel into the nitrocellulose membrane 
(Protran BA 85, Schleicher amd Schuell). A sponge, 2 or 3 3MM Whatmann filter 
papers, membrane, gel, again filter papers and sponge were put into a special cassette. 
The transferring of proteins into the membrane proceeded in the 4°C cold transfer 
(blotting) buffer containing 20% methanol and 1 x TBS (Tris-buffered saline, 25 mM 
Tris; 137 mM NaCl and 2,7 mM KCl), in the presence of ice (in order to avoid 
destruction of proteins by heat), at Bio-Rad machine (PowerPac HC, USA) at the 
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voltage 100 V for about 1 to 1,5 hour. The nitrocellulose membrane, filter papers and 
sponges should be incubated in transfer buffer in the fridge for about 10-15 minutes 
before transferring of the gel.  
After transferring of proteins into the membrane the non-specific bindings and 
sites on the membrane were blocked in the blocking buffer at RT with mild shaking 
for 1,5 hours. Blocking buffer contains 1 x TBS solution with 0,05% Tween 20 (also 
called TTBS) and 0,5% non-fat dried milk powder. Mainly milk has the blocking 
properties. Tween 20 serves as a surfactant. The blocking buffer helps to increase 
sensitivity and prevent non specific signal caused by cross-reactivity of the antibody 
and the blocked reagent. After this phase the membrane was incubated in primary 
antibody solution. 
 
3.2.4.5. Primary antibody 
 
 Primary monoclonal antibodies p53 and β-actin were diluted to the concentration 
1:1000 (p53, NCL-p53-DO7, Novocastra) and 1:3000 (β-actin, A1978, Sigma-Aldrich) 
in TTBS with 0.5% non-fat dried milk powder. The membrane was cut in a way, that 
p53 was identified in one part and β-actin in the other part. The membranes were put 
into the primary antibody solutions. This phase lasted at 4°C without shaking overnight. 
 
3.2.4.6. Secondary antibody 
 
 On the next day the membranes were washed by suspending in the washing 
buffer TTBS 4 x 8 minutes (increasing of washing buffer volume and the number 
of washes may reduce background, briefly rinsing membrane in washing buffer after 
incubation can increase wash efficiency), followed by incubation with secondary 
antibody solution at RT with shaking for 60 min. As secondary antibody was used horse 
radish peroxidase (HRP) conjugated immunoglobuline G (Ig G)  in concentration 
1:2000, diluted in TTBS with 0.5% non-fat milk powder. The secondary antibody 
specifically binds to the primary antibody and enables chemiluminiscence visualization. 
(The concentration depends on the HRP conjugate and the amount of antigen on the 
membrane). After this phase the membrane has been washed in TTBS 4 x 8 minutes 
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to remove non-bound HRP-conjugates. (Large blocking and washing buffer volumes 
may result in reduced non-specific signals).  
 
3.2.4.7. Visualization and analysis of proteins 
 
 The commercial chemiluminescent reagent (Super Signal West Pico, Pierce) was 
used to visualize the protein bands. The secondary antibody conjugated with HRP 
enzymatically effects these substrates, which causes a chemical reaction connected with 
the production of light, in other words chemiluminiscence.  
 The nitrocellulose membrane was put into the mixture (10 to 15 ml) of two 
reagents (Luminol/Enhancer and Stable Peroxide) in the rate 1:1 on the shaker for 
5 minutes, followed by putting the membrane into a plastic wrap, removing of the 
excess liquid and bubbles, and taking a chemiluminiscence picture 5 x 50 s CCD 
(charge-coupled device) by a camera (GeneSnap with GeneGnome, Syngene). 
The pictures were analysed with the GeneTools programme (Syngene).  
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4. RESULTS 
 
The aim of the MTT assay was to estimate the mitochondrial enzymatic activity, 
in otherwords if and how much the cells, treated with different juniper, laurel and basil  
extract concentrations, enzymatically reduce MTT and create formazan in comparisson 
to the untreated cells (creating of formazan is connected with the viable cells). In the 
LDH assay the amount of created enzyme lactat dehydrogenase produced in the 
damaged cells was measured. The SH-SY5Y neuroblastoma cells have been incubated 
with the extracts for 12 hours. The untreated cells were used as an experiment control. 
The MTT and LDH assay graphs show, how many percent of the control results were 
reached by the treated cells results. The experiments were done three times with three 
different, but similar cell samples. The average data of these three experiments were 
used for the creation of the graphs. The aim in Western blotting analysis was 
to determine the p53 protein level in the SH-SY5Y cells treated with the laurel and basil 
extracts. The beta-actin level has been used as a control. The untreated cells have been 
used as an experiment control. 
 
4.1. Juniper extract 
 
4.1.1. MTT assay 
 
 The Graph 1. shows, that 12 hours of incubation with the extract invoked 
significant decrease in MTT reduction in cells treated with the extract concentration 
2 mg/ml. The results did not reach 45% of the control. The results in four other 
concentrations 0,1; 0,5; 0,01 and 0,05 mg/ml reached less than 60% of the control 
results.  
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Graph 1. Reduction of MTT by SH-SY5Y-neuroblastoma cells after 12 hours 
of treatment with the juniper extract (n=3). 
 
4.1.2. LDH assay 
   
 The Graph 2. shows, that only in the case of cells treated with the extract 
concentration 2 mg/ml the amount of created LDH was much higher compared 
to control, almost 140% of the control. There were almost no differences between the 
treatments with the other extract concentrations 0,5; 0,1; 0,05 and 0,01 mg/ml. 
The production of LDH by SH-SY5Y neuroblastoma cells treated with these four 
extract concentrations was similar to the control. 
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LDH assay Juniper (12 h)
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Graph 2. Production of LDH by SH-SY5Y-neuroblastoma cells after 12 hours 
of treatment with the juniper extract (n=3). 
 
4.2. Laurel extract 
 
4.2.1. MTT assay 
 
 After 12 hours of incubation with the extract, as the Graph 3. shows, significant 
decrease in MTT reduction was observed in cells treated with the extract concentrations 
0,5 and 2 mg/ml. The results did not reach 20% of the control. The results in three other 
concentrations 0,1; 0,05 and 0,01 mg/ml reached less than 60% of control results.  
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MTT assay Laurel (12h)
Graph 3. Reduction of MTT by SH-SY5Y-neuroblastoma cells after 12 hours 
of treatment with the laurel extract (n=3).  
 
4.2.2. LDH assay 
 
 The Graph 4. shows, that only in the case of cells treated with the extract 
concentration 2 mg/ml the amount of created LDH was much higher compared 
to control, almost 160% of the control. The cells treated with the other extract 
concentrations 0,5; 0,1; 0,05 and 0,01 mg/ml did not show significant differences 
between each other and the amount of created LDH was similar to the control. Only in 
the case of cells treated with the extract concentration 0,5 mg/ml was the amount 
of created LDH just a few percent higher than in control.   
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LDH assay Laurel (12 h)
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Graph 4. Production of LDH by SH-SY5Y neuroblastoma cells after 12 hours of the 
laurel treatment (n=3). 
 
4.2.3. Western blotting analysis 
 
 The cells were treated with the extract concentration 0,1 mg/ml for different time 
periods (time-response experiment), which are shown in the Graph 5. From the graph is 
possible to see, that the cells treated with the extract even for long time period did not 
show increased p53 level compared to the control cells. These results come from only 
one experiment, so more experiments are needed to get reliable results. 
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Graph 5. Results of Western blotting analysis showing the p53 level in the SH-SY5Y-
neuroblastoma cells treated with the laurel extract for different time periods (n=1).  
 
In the Figures 11. to 13. there are pictures of SH-SY5Y neuroblastoma cells. 
These cells were used in the MTT test and their medium supernatant in the LDH test. 
These pictures were taken under microscope with the photocamera. In the Figure 11. 
there are the untreated control cells after 12 hours of incubation. In the Figure 12. there 
are cells after 12 h of incubation with the laurel extract concentration 0,5 mg/ml. In the 
Figure 13. there are cells after 12 h of incubation with the laurel extract concentration 
2 mg/ml. In the Figures 12. and 13. it is possible to see the morphological changes 
of treated cells in comparison to the untreated cells in Figure 11. The morphological 
changes mark the destruction of cells. 
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Figure 11. SH-SY5Y neuroblastoma control cells after 12 hours of incubation without 
extract. 
 
 
Figure 12. SH-SY5Y neuroblastoma cells after 12h of incubation with the laurel extract 
concentration 0,5 mg/ml. 
 
 
Figure 13. SH-SY5Y neuroblastoma cells after 12 h of incubation with the laurel 
extract concentration 2 mg/ml. 
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4.3. Basil extract 
 
4.3.1. MTT assay 
 
The Graph 6. shows, that 12 hours of incubation with the extract invoked the 
significant decrease in MTT reduction in cells treated with the extract concentration  
2 mg/ml. The results reached about 30% of the control. The cells treated with the other 
extract concentrations 0,5; 0,1, 0,01 and 0,05 mg/ml did not show big differences 
between each other and the reduction of MTT was in all four cases similar to the 
control.  
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Graph 6. Reduction of MTT by SH-SY5Y neuroblastoma cells after 12 hours 
of treatment with the basil extract (n=3). 
 
4.3.2. LDH assay 
 
 The Graph 7. shows, that only in the case of cells treated with the extract 
concentration 2 mg/ml the amount of created LDH was much higher compared 
to control, almost 150% of the control. The cells treated with the other extract 
concentrations 0,5; 0,1; 0,05 and 0,01 mg/ml did not show significant differences 
between each other and the amount of created LDH was similar to the control.  
 
 61 
LDH assay Basil (12 h)
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Graph 7. Production of LDH by SH-SY5Y neuroblastoma cells after 12 hours of basil 
extract treatment (n=3). 
 
4.3.3. Western blotting analysis 
 
The cells were treated with the extract concentration 0,5 mg/ml for different time 
periods (time-response experiment), which are marked in the Graph 8. The graph 
shows, that the cells treated with the extract for 24 and 30 hours embody a little bit 
higher p53 level compared to control, but the difference is only about 10%. 
After shorter incubation time with the extract the cell‘s p53 level was lower compared 
to the control. These results come from just two experiments, so more experiments are 
necessary to get reliable results.   
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Graph 8. Results of Western blotting analysis showing the p53 level in the SH-SY5Y 
neuroblastoma cells treated with the basil extract for different time periods (n=2). 
 
In order to compare the effects of juniper, laurel and basil extracts, the results of MTT 
and LDH assays with all three extracts are shown in the Graph 9. and 10. 
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Graph 9. Reduction of MTT by SH-SY5Y-neuroblastoma cells after 12 hours 
of treatment with the juniper, laurel and basil extracts (n=3). 
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Graph 10. Production of LDH by SH-SY5Y-neuroblastoma cells after 12 hours 
of treatment with the juniper, laurel and basil extracts (n=3). 
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5. DISCUSSION 
 
 Plant-derived polyphenols and other drug substances are easily approachable, 
because they occur in high amounts in plants, herbs, fruits and vegetables, which are 
part of the human diet and which were and still are used against many human diseases 
in the traditional medicine all over the world (Fresco 2006). 
 Nowadays, polyphenols are of a big interest in research, because they have many 
therapeutical properties. Some of these properties are not discovered yet and there are 
not many information about the discoverd activities. Especially the mechanisms 
of action are very often missing and are questions for research. 
 However, the anticancerogenic properties of phenolic compounds are well 
known. It has been shown cancer to be a largely preventable disease, highly susceptible 
to modulation by dietary factors (Fresco et al. 2006, Yang et al. 2001). For example, 
a diet high in fruits reduces oxidative damage to DNA, which may be one critical step 
in the onset of some types of cancer. Protective effect of fruits and vegetables intake 
was proved against lung, colon, breast, cervix, esophagus, oral cavity, stomach, bladder, 
pancreas and ovary cancer (Nichenametla et al. 2006). Increased tea consumption was 
associated with lower risk for breast cancer metastasis and recurrence. Frequent 
consumption of green tea showed lower incidence of esophageal cancer (Yang et al. 
2001). The phenolic compounds might affect the molecular events in the initiation, 
promotion and progression stages of carcinogenesis (Yang et al. 2001). 
In this work, a cell model was used. The cells were treated with plant extracts 
from laurel leaves, juniper berries and basil leaves. The effects of plant extracts on cell 
viability were examined. The effects of laurel and basil on p53 protein level in the SH-
SY5Y neuroblastoma cells were examined already earlier (Lantto 2006). It was also 
shown, that basil essential oil has antioxidant activity (Zheljazkov et al. 2008), 
the major antioxidant compound in basil is rosmarinic acid (Jayasinghe et al. 2003) and 
the antioxidant activity is dose-dependent (Gülçin et al. 2007). Basil has 
antiproliferative effect on mesangial cells (Makino et al. 2002) and its extract supresses 
carcinogenesis (Aruna et al. 1990). The antioxidant activity might participate in the 
effect against cancer, but more experiments are needed to prove this potential property 
of basil. 
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 The main component of laurel essential oil 1,8-cineole induces apoptosis and 
supresses the growth of human leukemia cells (Moteki et al. 2002). Other important 
component cinnamtannin B-1 has radical scavenging activity with antioxidant 
properties. Cinnamtannin B-1 enhances caspase-3 activity and induces apoptosis in the 
cancer cells, not in the healthy cells (Ben Amor et al.  2007, Bouaziz et al. 2007). 
Also polyphenolic flavonol aglycones isoquercetin and kaempferol have antioxidant 
properties (Soobrattee et al. 2005). 
 Juniper extract from berries and leaves possesses antioxidant activities (Emami 
et al. 2007) and decreases the growth of breast cancer cells, liver and colon carcinoma 
cells (Bayazit et al. 2004, Slambrouck et al. 2007). 
In this work in the MTT and LDH assay the extracts in the concentrations 0,01; 
0,05; 0,1; 0,5 and 2 mg/ml were effecting the cells for 12 hours. In the Western blotting 
analysis the cells were treated with the laurel extract concentration 0,1 mg/ ml for 12, 
24, 36, 48 and 72 hours, and with the basil extract concentration 0,5 mg/ml for 6, 12, 
24, 30 and 48 hours. 
 In the MTT test, a significant effect was observed by all extracts in the 
concentration 2 mg/ml. In the case of juniper the concentration of created formazan did 
reach around 40 % of the control, under influence of basil not even 40 % and by laurel 
less than 20 % of the control. Laurel was very effective also in the concentration 0,5 
mg/ml - the activity of reducing enzymes did not reach 15 % of the control. All other 
concentrations of laurel and juniper extract showed also significant activity with the 
results reaching less than 60% of the control. It is possible, that longer exposure of the 
extracts, especially of laurel, could show bigger differences in the results in comparison 
to the controls. 
 In the LDH test, the cells treated with all three extracts at concentration 2 mg/ml 
did show significantly higher amount of the enzyme lactate dehydrogenase and its 
activity compared to the control. In the case of laurel and basil the reasults reached 
around 150 % of the control, by juniper a little bit less than 140 % of the control. 
The cells treated with all three extracts at four other concentrations did not produce 
significantly more lactate dehydrogenase enzyme than the control cells. 
It is possible to see the differences between the MTT and LDH assay results.  
These dissimilarities might occur, because the principle of MTT and LDH assay vary 
and various substrates are used to measure the viability of cells. It is also possible, that 
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mitochondria does not work anymore, which shows MTT test, while there are no 
changes in the integrity of cell membrane yet, which is shown in the LDH test. 
From Western blotting analysis by cells treated with basil extract is possible 
to see a little bit higher p53 level after 24 and 30 hours of treatment in comparison 
to control. After 6, 12 and 48 hours the p53 level in cells was lower compared 
to control. Western blotting analysis with laurel extract does not show any significantly 
higher p53 levels in cells compared to control, not even after 72 hours of treatment. 
However, only one experiment was done with the laurel extracts and two with the basil 
extract. The results are therefore not valid and more experiments are necessary to get 
reliable results.  
Important point of view in all three used methods is the fact, that the enzyme 
activity and p53 level is measured within small 96-well plate or in small plastic plates, 
where the cells grow principally isolated and they are not part of the whole organism. 
Thus, it is very important to implement the in vivo experiments, which would show, 
how the extracts behave inside the organism. It could be possible to see, if the extracts 
reach the effective concentrations in the blood after peroral or intravenous application, 
and how the cells react within the body.  
 It was also proved, that some substances exude apoptosis in low concentrations, 
whilst in higher concentrations cause necrosis. It is therefore very important to examine, 
if apoptosis or necrosis proceeds in the cells, and what can influence the ,,decision‘‘ 
of the cells for apoptosis. 
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6. CONCLUSION 
 
 From the experiment results on cell models in this study imply, that the plant 
extracts are effecting the human SH-SY5Y-neuroblastoma cells and their viability. 
These properties very much depend on the concentration and exposure time. My results 
show, that the effect is higher with higher concentration and exposure time. All the 
three extracts or their components embody antioxidant activity, which might 
in according to previous studies participate on their anticancerogenic properties. It is 
necessary to examine the extracts on the animal models to further understand the 
biological effects of these three extracts, especially the mechanism of their activity, 
their eventuall toxicity in high doses in the organism and eventually to discover their 
unknown active components.      
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8. SUPPLEMENTS 
 
8.1. Time-response experiments with laurel and basil 
extracts using Western blotting analysis 
 
 The bands in Figure 1. (chemiluminiscence picture) show the time-dependent 
p53 and beta-actin level in the cells treated with the laurel extract concentration 0,1 
mg/ml for 12, 24, 36, 48 and 72 hours. The mark c means control, no treatment with the 
extract. In the Figure 1 there are two pictures, because the samples were transferred into 
two gels in one experiment (for the case, something would not work in one of the gels). 
Figure 1. Chemiluminiscence picture of the nitrocellulose membrane, showing the 
time-dependent p53 and beta-actin level in the SH-SY5Y neuroblastoma cells after 
treatment with the laurel extract concentration 0,1 mg/ml in the time. The time points 
were 12, 24, 36, 48 and 72 hours, c means control (0h). 
 
The bands in the Figure 2. (chemiluminiscence picture) show the time-dependent p53 
and beta-actin level in the cells treated with the basil extract concentration 0,5 mg/ml 
for 6, 12, 24, 30 and 48 hours. The mark c means control, no treatment with the extract. 
In the Figure 2. there are two pictures, because the samples were transferred into two 
gels in one experiment. 
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Figure 2. Chemiluminiscence picture of the nitrocellulose membrane, showing the 
time-dependent p53 and beta-actin level in the SH-SY5Y neuroblastoma cells after 
treatment with the basil extract concentration 0,5 mg/ml in the time. The time points 
were 6, 12, 24, 30 and 48 hours, c means control (0h). 
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9. APPENDIX - SUMMARY IN CZECH 
  
 Apoptóza hraje důleţitou roli v procesu udrţování homeostázy v dospělém 
organismu. Podílí se na odstraňování nepotřebných, nadbytečných a poškozených buněk 
a je v rovnováze s mitózou. Nadměrná nebo naopak nedostatečná apoptóza se můţe 
projevit jako onemocnění člověka, např. Alzheimerova choroba nebo nádory. 
 V dnešní době se k léčbě rakoviny uţívají především chemická léčiva, která mají 
hodně neţádoucích účinků. Proto se současná věda zabývá zkoumáním i přírodních 
látek, jejichţ některé účinky jsou známé z uţívání v tradiční medicíně a některé 
potenciálně působí protinádorově. Ve své práci jsem se zabývala působením rostlinných 
extraktů z vavřínu, jalovce a basalky na ţivotaschopnost lidských SH-SY5Y buněk 
neuroblastomu. 
Existují dva druhy buněčné smrti - apoptóza a nekróza. Nekróza je proces 
patologický, vyvolaný většinou škodlivými chemickými a fyzikálními faktory, který 
zpravidla vede k zánětlivé reakci. Apoptóza je fyziologický a geneticky 
naprogramovaný proces buněčné smrti, který je charakteristický scvrkáváním buněk, 
chromatinovou kondenzací a tvorbou apoptotických tělísek. Není doprovázena 
zánětlivou reakcí. Apoptóza je regulována mnoha různými proteiny. Mezi důleţité 
regulátory patří kaspázy, cystein-aspartyl proteázy, které jsou v buňce produkovány 
jako neaktivni proenzymy, takzvané prokaspázy. Prokaspázy musí být aktivovány 
proteolytickým štěpením, aby mohly plnit svou funkci. Kaspázy jsou rozděleny do dvou 
skupin, na efektory a iniciátory. Efektory (nazývané téţ exekutory), jako jsou kaspáza-
3, -6 a -7, spouštějí apoptózu a jejich aktivace vede k typickým morfologickým změnám 
buněk. K jejich aktivaci jsou nutné iniciátory, jako jsou kaspáza -2, -8, -9 a-10, které 
jsou schopny aktivovat se samy autolytickou reakcí. Aktivace kaspáz můţe být 
dosaţena dvěma různými mechanismy, a sice mitochondriální neboli vnitřní cestou 
a death receptor neboli vnější cestou. 
Vnitřní cesta se odehrává v mitochondrii. Po příchodu apoptotického signálu 
do mitochondrie, je z její vnitřní membrány uvolněn cytochrome c. V cytosolu 
cytochrome c oligomerizuje a s cytosolickým adaptor proteinem Apaf-1 vytváří 
komplex zvaný apoptosome. Apoptosome působí na prokaspázu-9, která se autolyticky 
štěpí na kaspázu-9. Kaspáza-9 pak aktivuje kaspázy-3,-6 a -7.  
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Death receptory jsou situovány na povrchu buněk a patří do skupiny TNF 
proteinů. Death receptor cesta je spuštěna při navázání death receptorů (Fas,  TNFR-1, 
DR5) k jejich ligandům (FasL, TNF-alpha, TRAIL), které také patří do skupiny TNF 
proteinů. Tato vazba vede k oligomerizaci death receptorů, které navázáním 
adaptorového proteinu FADD vytváří tzv. death-inducing signalling komplex (DISC). 
DISC aktivuje prokaspázu-8. Prokaspáza-8 se autolyticky štěpí na kaspázu-8, která 
aktivuje kaspázu-3 a -7. Kaspáza-3 poté štěpí proapototický protein Bid, který se 
přemístí do mitochondrie. Bid v mitochondrii vyvolává uvolnění cytochromu c, coţ dále 
rozvíjí proces apoptózy.  
 p53 je protein, který inhibuje růst buněk. V niţší koncentraci zastavuje buněčný 
cyklus ve fázi G1, ve vyšší koncentraci způsobuje apoptózu. p53 působí biologicky jako 
tumor supressor a biochemicky jako transkripční faktor, který reguluje transkripci 
cílových proteinů. Aktivuje pro-apoptotické geny (Bax, Puma, Noxa), potlačuje anti-
apoptotické geny (Bcl-2) a geny zajišťující přeţití buňky (survivin). p53 hraje důleţitou 
roli  v mitochondriální i death-receptor apoptotické cestě. Poruchy produkce proteinu 
p53 mohou vést k různým lidským chorobám. Nadměrná funkce p53 vede např. 
k autoimunitním chorobám a k neurodegenerativním chorobám. Sníţená funkce 
proteinu p53 můţe být příčinou vzniku rakoviny. Právě mutace p53 jsou velmi často 
pozorovány u rakovinných onemocnění.  
 Mitochondriální apoptotická cesta je regulována pro- a antiapoptotickými členy 
Bcl-2 skupiny proteinů. Mezi proapoptotické členy, které apoptózu vyvolávají, patří 
Bid, Bad, Bim, Bax a Bak. Mezi antiapoptotické členy, které apoptózu inhibují, patří 
Bcl-2 a Bcl-xL. Aktivace nebo inhibice apoptózy závisí na tom, které z faktorů 
převaţují. K dalším důleţitým proteinům, které ovlivňují apoptózu patří apoptosis-
inducing factor, který po příchodu apoptotického signálu způsobuje chromatinou 
kondenzaci, a inhibitor of apoptosis protein, který antagonizuje aktivaci kaspázy-3. 
Důleţitý je rovněţ Smac/ Diablo protein, který neutralizuje apoptosis-inducing factor. 
Obě apoptotické cesty se sbíhají na úrovni kaspázy-3, která štěpí další buněčné 
substráty. 
Cytosine arabinoside (AraC) je pyrimidinový antimetabolit, který je v dnešní 
době hlavní látkou pouţívanou v léčbě akutní leukemie. Jeho přesný mechanismus 
účinku není známý. Pravděpodobně se inkorporuje do nově syntetizované DNA buňky, 
způsobuje poškození DNA. Podporuje rovněţ tvorbu reaktivního oxygen species, 
coţ vede k produkci p53 proteinu a indukci apoptózy. Ovšem AraC indukuje apoptózu 
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také zdravých buněk v závislosti na čase a dávce. Proto je limitujícím faktorem 
v uţívání AraC při léčbě leukemie jeho hlavní neţádoucí účinek neurotoxicita. 
Rostlinné polyfenoly jsou jejich sekundární metabolity, které jsou syntetizovány 
z phenyalaninu takzvanou šikimátovou syntézou. Vyskytují se ve velkém mnoţství 
v ovoci, zelenině a bylinách. Mohou být tedy bohatě zastoupeny v potravě člověka. 
Pro rostliny  mají  především význam ochranný (před škůdci, fotosyntetickým stresem) 
a jsou důleţité pro jejich růst a rozvoj. 
 Polyfenoly mají také řadu biologických funkcí, jako jsou antibakteriální, 
antivirové, protizánětlivé, vazodilatační nebo protirakovinné. Důleţité jsou také 
vlastnosti antioxidační a schopnost shášet volné radikály, které se mohou podílet nejen 
na protirakovinném účinku, ale také mohou být potenciálně pouţity v léčbě diabetu 
nebo kardiovaskulárních onemocnění. Limitujícím faktorem pro klinické uţívání 
rostlinných polyfenolů je jejich velmi nízká biologická dostupnost v krvi, protoţe 
procházejí mohutnou metabolizací v lidském trávicím traktu. Polyfenoly jsou velmi 
rozsáhlou skupinou rostlinných sloučenin. Mezi nejznámější patří flavonoidy, fenolické 
kyseliny, stilbeny, taniny, lignany a kumaríny.  
Bazalka je rostlina patřící do čeledi Lamiaceae. Hlavními obsahovými látkami 
esenciálního oleje z natě bazalky jsou linalool, methylchavikol, eugenol 
a methyleugenol. Zastoupení jednotlivých sloţek závisí zejména na prostředí, ve kterém 
rostlina roste. U esenciálního oleje byly prokázány účinky antioxidační (hlavní 
antioxidační látkou je kyselina rozmarinová), antimikrobiální, hepatoprotektivní 
a karminativní. Důleţitý ja také účinek protirakovinný. Byl prokázán např. 
antiproliferativní účinek na leukemické a epidermální rakovinné buňky. 
 Vavřín patří do čeledi Lauraceae a hlavními obsahovými látkami jeho listů jsou 
1,8-cineol, cinnamtannin B-1 a seskviterpeny. 1,8-cineol indukuje apoptózu a potlačuje 
růst leukemických buněk v závislosti na čase a dávce. Cinnamtannin B-1 působí silně 
antioxidačně, sháší volné radikály a zvyšuje aktivitu caspázy-3, čímţ indukuje 
apoptózu, jak bylo zjištěno, pouze v tumorálních buňkách, nikoli v buňkách zdravých. 
Toto působení zatím nebylo jasně vysvětleno. Také seskviterpeny projevily 
cytotoxickou aktivitu v lidských leukemických buňkách. 
 Jalovec patří do čeledi Cupressaceae. Mezi hlavní obsahové látky esenciálního 
oleje z listů i plodů patří alfa-pinen, beta-pinen a sabinen. Kromě účinků 
antimikrobiálních a antioxidačních, je důleţitý také protirakovinný efekt např. proti 
jaterním nebo střevním karcinomatickým buňkám. 
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 Vliv extraktů z bazalky, vavřínu a jalovce na apoptózu jsem ve svých 
experimentech zjišťovala pomocí metod MTT a LDH assay, které zjišťují 
ţivotaschopnost buněk, a metodou western blotting analýzy.  
Výsledky MTT assay udávají mnoţství vzniklého formazanu, který je vytvářen 
z MTT ((3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)) činností 
dehydrogenáz a redukujících enzymů v ţivých buňkách. Mnoţství vytvořeného 
formazanu se měří spektofotometricky a je principielně úměrné mnoţství ţivých buněk. 
Laktát dehydrogenáza (LDH) je enzym, který je produkován poškozenými buňkami. 
V LDH testu laktát dehydrogenáza přeměňuje laktát na pyruvát, přičemţ při této reakci 
vzniklý NADH katalyzuje přeměnu iodonitrotetrazolia na formazan. Mnoţství 
vzniklého formazanu je měřeno spektrofotometricky. Cílem western blotting analýzy 
bylo zjistit hladiny proteinu p53 v buňkách po různých dobách působení extraktů. 
Ve všech testech byly výsledky experimentů s buňkami, na něţ extrakt působil, 
srovnáván s výsledky experimentů s buňkami, které byly po příslušnou dobu 
inkubovány, ale na něţ extrakt nepůsobil, a které tedy slouţily jako kontrola. 
V MTT a LDH testu působily na buňky všechny tři extrakty v koncentraci 
2; 0,5; 0,1; 0,05 a 0,01 mg/ml po dobu 12 hodin. U všech tří extraktů v koncentraci 
2 mg/ml byl v MTT testu zaznamenán signifikantní pokles redukce MTT. V případě 
jalovce tvořila redukce MTT 40% kontroly, v případě vavřínu méně neţ 20 % 
a u bazalky kolem 30%. Velmi účinná se ukázala být v případě vavřínu také 
koncentrace 0,5 mg/ml, jejímţ působením klesla redukce MTT pod 15% kontroly. 
Působení ostatních tří koncentrací vavřínu a čtyř koncentrací jalovce způsobily pokles 
redukce MTT pod 60% kontroly. V případě basalky byl vidět nepatrný rozdíl mezi 
kontrolou a buňkami, na něţ působil extrakt v ostatních čtyřech koncentracích. 
Ve výsledcích LDH testu je moţné pozorovat výsledky částečně podobné. Projevil se 
opět velký účinek všech tří extraktů v koncentraci 2 mg/ml, kdy mnoţství vytvořeného 
LDH dosáhlo v případě jalovce skoro 140%, u basalky kolem 150% a u vavřínu skoro 
160% kontroly. Jiné koncentrace všech tří extraktů nezpůsobily signifikantní rozdíl 
v mnoţství vytvořeného LDH ve srovnání s buňkami kontrolními. Rozdíly 
ve výsledcích MTT a LDH testu jsou dány pravděpodobně tím, ţe mitochondrie uţ 
nefungují, ale zatím nebyla porušena integrita celulární membrány. Rozdíly mohou být 
způsobeny také rozdílnými principy metod MTT and LDH assay.  
Ve Western blotting analýze byly buňky vystaveny působení roztoku vavřínu 
v koncentraci 0,1 mg/ml po dobu 12, 24, 36, 48 a 72 hodin, a roztoku bazalky 
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v koncentraci 0,5 mg/ml po dobu 6, 12, 24, 30 a 48 hodin. V případě vavřínu nebyla 
pozorována zvýšená hladina proteinu p53 oproti kontrole, ani po inkubaci 72 hodin. 
V případě bazalky byla hladina proteinu p53 mírně zvýšena oproti kontrole pouze 
po inkubaci 24 a 30 hodin.  
Z výsledků mých experimentů vyplývá, ţe všechny tři extrakty jsou schopny 
ovlivňovat ţivotaschopnost SH-SY5Y buněk neuroblastomu. Tato schopnost silně 
závisí na koncentraci extraktu. Se zvýšenou koncentrací extraktu jeho účinek roste. 
Ve svých experimentech jsem pouţívala v případě MTT a LDH testu inkubační čas 
pouze 12 hodin. Je moţné, ţe po delší inkubaci s extraktem by mohly být i niţší 
koncentrace účinnější. Důleţitou roli v těchto experimentech hraje poznatek, ţe buňky 
jsou ţivé organismy, které se mohou chovat velmi růzonorodě podle podmínek, 
ve kterých se nacházejí a ţijí. Tento fakt můţe mít velký vliv na výsledky experimentů.  
